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ABSTRACT
The role of

conceptus-derived

immunosuppressive

factors

in

protecting the fetal allograft was investigated by first examining the
immunosuppressive activity derived from ovine,
conceptus

trophoblast

tissue.

Medium

caprine and hybrid

conditioned

by

20

day-old

conceptus trophoblast tissue from each species suppressed sheep and
goat lymphocyte proliferation

(Pc.01).

There were no differences

(P>.05) between the immunosuppressive effects of the three media on
either sheep or goat

lynphocytes.

In

subsequent

studies,

horse

conceptus-conditioned medium (HCCM) derived from embryos at days 9, 15
and 26 of gestation, suppressed mitogen-stimulated horse lynphocytes
(Pc.001). HCCM maintained its suppressive activity following heating
and repeated freeze-thawing. Using microconcentrator centrifugation,
it was determined that the suppressor factor(s) was >100,000 MW. HCCM
was tested in donkey and goat lymphocyte cultures and proved capable
of

suppressing proliferation

However,

of

xenogeneic

lynphocytes

(Pc.01).

the suppressive capacity of HCCM in caprine lymphocyte

cultures was less (P<.05) than that in equine cultures. Trophoblast
tissue of 21 day-old horse conceptuses was cultured in the presence
and absence of indomethacin. Both immunosuppressive activity and the
concentration of prostaglandin E2 (PGE2 ) in the medium of each culture
were measured. While PGE2 production was greatly reduced in cultures
containing

indomethacin,

trophoblast-derived

immunosuppressive

activity was not affected (P>.05). The final stud/ involved partial
characterization of the HCCM suppressor factor's (HCCM-SF) mechanism
of action. By testing HCCM-SF in cultures stimulated with mitogens
ix

that selectively activate B and/or T lynphocytes, and ky sorting HCCMSF-treated and non-treated cells labeled with fluorescent antibodies,
it was determined that HCCM-SF acts on T lynphocytes. The temporal
effect of HCCM-SF was also investigated and, compared to lynphocytes
treated at time 0, proliferation was greater

(Pc.01)

in cultures

treated with HCCM-SF 24 or 48 hours after the start of stimulation.
Furthermore, the removal of HCCM-SF from lymphocyte cultures resulted
in

complete

recovery

of

cell

responsiveness.

The

addition

of

recombinant human IL-2 to the lymphocyte cultures did not overcome the
suppressive effect of HCCM-SF (Pc.01), yet HCCM-SF had no effect on
cells already expressing the high affinity IL-2 receptor

(P>.05).

HCCM-SF may be one factor responsible for inhibiting cell-mediated
fetal allograft rejection during pregnancy.

x

INTRODUCTION
The mammalian placenta mediates numerous supportive functions
related to the fetus that are necessary for maintaining a successful
pregnancy. In acting as the organ of fetal respiration, nutrition, and
excretion, the placenta facilitates metabolic exchanges between fetal
and maternal blood

while

simultaneously

movement of many other substances.

impeding

The placenta

transplacental
also

plays

an

important role as an endocrine organ during gestation, but perhaps its
most fascinating characteristic is the ability to maintain the fetus
as an allograft in the mother.
Scientists have struggled for years to understand how nature
circumvents the allograft reaction to allow for fetal survival. The
motives for studying this phenomenon have been primarily two-fold.
First, it is believed that some cases of infertility and recurrent
abortion result from aberrant immunological conditions, but causal,
atypical immunological events can only be identified and appropriately
treated if the "normal" fetal-maternal relationship of successful
pregnancies

is understood.

Second,

information

gained

from

the

elucidation of the mechanisms underlying fetal allograft tolerance
might prove valuable for those struggling to improve the proficiency
of organ transplantation. While both motives still exist today, there
is now a third and perhaps more critical incentive for solving the
mysteries surrounding maternal acceptance of foreign fetal tissue.
This third motive pertains to potential strategies for assisting
reproduction of endangered species.
While the human population is expanding at an accelerated rate,
xi

species diversity on this planet is diminishing at a similarly
alarming rate. In order to both protect and enhance proliferation of
endangered species,

it is imperative that some action be taken

immediately. With the technological advances of the past decade,
interspecific

embryo

transfer

from

endangered

to

non-endangered

species has become an attractive strategy, unfortunately, the use of
this procedure has met with only limited success. The etiology of
failed interspecies pregnancies
rejection.

Therefore,

comprehensive

it

understanding

is
of

frequently indicates imnunological
anticipated
the

that

by

fetal-maternal

achieving

a

imnunological

relationship, it will be possible to either choose more appropriate
xenogeneic surrogate females or to modulate the in utero immune
response of the surrogates such that the interspecific pregnancy is
maintained. Perhaps then, the success of interspecific embryo transfer
will attain the efficiency required to facilitate the propagation of
sane imperiled species.
In this dissertation, one immunological aspect of the fetalmaternal relationship is examined. In order for the reader to gain
insight into the philosophy of this work, the literature review in
Chapter I encompasses three main topics. The first section describes
components of the immune response

that

contribute

to

allograft

rejection and that may play a role in the acceptance or rejection of
the fetal allograft.

The second section

focuses

on

the

large,

convincing bod/ of evidence for the importance of the placenta in both
protecting the fetal allograft and maintaining pregnancy. The final
section of the literature review deals specifically with the concept
xii

of immunosuppression at the fetal-maternal interface, which is the
focus of this research. Chapters II-V consist of the four manuscripts
derived from this dissertation.

CHAPTER

I.

LITERATURE
IMMUNE

RESPONSES
The

AND

History

REVIEW
ALLOGRAFT

of

REJECTION

Allografts

An allograft is a tissue that has been transplanted from one
member of a species to another genetically distinct member of that
species.

The first allograft attempt was reported in 1503 by a

surgeon who grafted skin from a slave for the reconstruction of the
master's nose (from Auchincloss and Sachs,

1989).

Skin grafting

became common practice during the late 1800s, but it was mainly a
technique used to promote the healing of a wound, and whether or not
the graft "took", was of no great concern.

A tremendous break-through

for those studying graft acceptance and rejection in the early 1900's
came from the observations of Sir Peter Medawar.

Medawar critically

evaluated some peculiar results of a clinical skin graft attempt and
subsequently carried out a series of grafting experiments in rabbits
(Medawar,

1944).

Shortly thereafter,

rejection of allografts was a
reactions

(Medawar,

1945).

Medawar

concluded

that

the

form of actively acquired immune

Little

(1914,

1941)

also made

an

exceptional contribution towards our understanding of the success or
failure

of

transplantation

transplantation".

by

describing

the

“laws

of

These laws dealt with the genetic components

contributing to graft rejection.

In his interpretation of the

complicated laws, Little proposed that there were multiple loci
codominantely expressing their products, and if any such product was
generated by the donor and not the recipient, the graft would be
1

2

rejected

(Little, 1914).

Little's hypothesis

(now considered a

fundamental law) was largely responsible for stimulating subsequent
investigations that led to the identification and characterization of
the major

histocompatibility

complex

(MHC)

loci

and

associated

antigens.
Today, we know that the extraordinarily polymorphic MHC antigens
(Bell et al., 1985) can be divided into two general types called class
I and class II MHC antigens.

The class I antigens are found on

virtually all nucleated cells of the body (Harris and Gill, 1986).

In

contrast, class II antigens are selectively present on several immune
cells, such as macrophages, dendritic cells, B lymphocytes and human T
lymphocytes (Daar et al., 1984).
identified by antibodies.

Initially, class I antigens were

In contrast,

class II antigens were

identified by their ability to provoke allogeneic lymphocyte responses
(Bach et al., 1972).

Such responses are not unlike those that occur

during allograft rejection.
Humoral Immune-mediated Graft Rejection.
Because B lymphocytes are responsible for the generation of
antibodies, their primary role in graft rejection is mediated through
a humoral immune response.

There is sane evidence that pre-existing

antibodies can cause antibody-mediated (hyperacute) graft rejection of
vascularized organs

(Williams et al.,

1968).

Such rejection is

characterized by antibody binding to vascular endothelium which leads
to

severe

thrombosis

(Winn,

1986).

Chronic

antibody-mediated

rejection has been implied in a few failed cases of transplantation
where only a sparse cellular infiltrate was observed (Jeannet, 1970).
However, a well defined mechanism for chronic humoral immune-mediated

3

graft rejection has not been identified.

Furthermore, skin grafts are

resistant to hyperacute antibody-mediated rejection
1973).

(Winn et al.,

Instead, cell-mediated imnunological processes are responsible

for skin graft rejections which occur one or more weeks following
transplantation.

Because

the

placental-uterine

association

is

analogous to a skin graft-donor relationship, it is the cell-mediated
response, or lack thereof, during pregnancy that receives the most
attention when survival of the fetal allograft is studied.
Cell-mediated Graft Rejection.
Skin graft rejection is a highly specific and complex process
involving both B and T lynphocytes, macrophages and natural killer
(NK) cells (Hayxy et al., 1984; Tilney et al., 1984).

Experiments in

which syngeneic and allogeneic skin grafts were placed adjacent to
each other resulted in an inflammatory rejection response to the
allogeneic graft, yet the response abruptly ended at the interface of
the syngeneic graft (Auchincloss and Sachs, 1989).

Furthermore, when

mosaic grafts of chimeric (tetraparental) mice were transferred to one
of

the

parents,

only

allogeneic

cells

were

destroyed

while

interspersed syngeneic cells were left unharmed (Mintz and Silvers,
1970; Rosenberg and Singer, 1988). The specificity of graft rejection
is a reflection of the T cell receptor's (TCR) specificity for foreign
cells.
T Lymphocytes
The importance of T lynphocytes in cell-mediated graft rejection
has been demonstrated in vitro fcy their role in non-antibody mediated
cytotoxicity, and in vivo fcy their significant predominance in the
cellular filtrate of rejected transplants.

Further confirmation has

4

been obtained experimentally by

the demonstration

that

T

cell

deficient rats indefinitely accept cardiac allografts (Iga et al.,
1985) and athymic mice accept not only allogeneic grafts, but also
xenogeneic grafts (Manning et al., 1973).
are re-populated with purified T

In addition, when such mice

cells,

the animals regain the

capacity to reject grafts (Sprent et al., 1986; Rosenberg et al.,
1987).

While it is widely accepted that T cells are largely

responsible for graft rejection, there is still controversy regarding
the specific T cell subsets or mechanisms involved (Steinmuller, 1985;
Mason and Morris, 1986).
T cell development is accompanied by changes in cell surface
structures and these surface antigens serve as phenotypic markers for
cells with different physiological functions.

The T cell population

is divided into two general sub-populations on the basis of the
expression of the specific cell surface antigens,

CD4

and CD8

(Reinherz and Schlossman, 1980; Raff, 1971; Cantor and Bqyse, 1975).
Expression of the CD4 and CD8 antigens is associated with the function
of the cells.

Thus, CD4+ cells are known as T helper cells and CD8+

cells are T cytotoxic/suppressor cells.

CD4 and CD8 antigens are also

involved in and predict the TCR's mechanism of antigen recognition.
The TCR of CD4+ cells recognize antigen in the context of class II MHC
while the TCR of CD8+ cells recognize antigen in the context of class
I MHC (Swain, 1983). Reconstitution of T cell-deficient mice with
either CD4+ or CD8+ T cell populations re-establishes the animal's
ability to reject grafts (Wheelahan, 1987; Auchincloss et al., 1988).
It has been reported that rejection of grafts expressing only class I
antigenic differences is dependent on CD8+ lynphocytes while CD4+ cell

participation is required for rejection of grafts expressing only
class

II

differences

(Rosenberg

et

al.,

1986,1987).

These

observations are compatible with the theory that the T cell, and more
specifically TCR recognition of foreign MHC,

is responsible

for

rejecting grafts.
T..Lymphocyte Activation
In a primary immune response, T cell activation occurs when the
antigen specific TCR is stimulated by a foreign antigen in the context
of an appropriate MHC antigen.

Following activation,

the cell

undergoes dramatic changes including an increase in cell volume (blast
transformation), an increase in ENA synthesis and the generation of
specific cell products.
specific T cells.

These events result in clonal expansion of

Additionally, the cells differentiate and acquire

specific functions associated with T helper or T cytotoxic/suppressor
cells.
serves

T helper cells (CD4+) produce interleukin-2
as

the

necessary

secondary

signal

(IL-2) which

(following

antigen

stimulation) for inducing proliferation of T cells (Bonnard et al.,
1979; Smith, 1980) as well as for generating OIL activity (Farrar et
al., 1981).

The ability of T cells to respond to IL-2 depends on

activation of the cells to express the high affinity IL-2 receptor
(IL-2R) (Bonnard et al., 1979; Smith, 1980).
The IL-2 Receptor
The

IL-2R has

been

identified and described as

a

dimer

consisting of a p55 alpha chain with low affinity for IL-2 and a p75
beta chain with slightly greater IL-2 affinity (Greene et al., 1986;
Tsudo et al., 1986; Teshigawara et al., 1987; Smith, 1988a).

With

mitogenic or allogeneic stimulation, the two chains are expressed

together on the cell surface to form the high affinity IL-2R complex
which, when bound to IL-2, is largely responsible for signaling cell
proliferation (Sharon et al., 1986; Smith, 1988b).

The significance

of this high-affinity IL-2R has been demonstrated fcy experiments in
which an antibody to the IL-2R (anti-Tac) blocks IL-2 binding (Robb et
al.,

1981; Leonard et al.,

inhibiting cell proliferation
antibody blocking of the

1982; Sharon et al.,
(Robb et al.,

IL-2/IL-2R

1986),

1981).

In addition,

interaction has

prevented allograft rejection (Kirkman et al., 1985).

therefcy

effectively

While T helper

cells serve as the source of IL-2, IL-2R are expressed on T helper, T
cytotoxic/suppressor and even activated B cells (Waldmann et al.,
1984).

Thus, IL-2 can have a significant inpact on several cell types

involved in cell-mediated immune responses.
Cvtotoxic T Lymphocytes
Cytotoxic T cell differentiation and activation are dependent on
IL-2 production fcy T helper cells (Nabholz and MacDonald, 1983).

This

effect of IL-2 is largely responsible for the synergism of the two
cell types that has been observed both in vivo (Cantor and Asofsky,
1971) and in vitro (Wagner, 1973).

While IL-2 has been promoted as

the lymphokine responsible for the secondary stimulus required for
complete CIL activation, it has recently been reported that IL-4 may
be equally effective in its ability to serve as a helper factor for
CIL generation

(Widmer and Grabstein,

1987).

Nevertheless,

IL-2

induction of CIL proliferation may be an important event associated
with graft rejection.

Convincing evidence exists for CIL involvement

in the rejection process.

For

example,

using

flow cytometric

analysis, a shift in the ratio of CD4+ to CD8+ cells (from 1.6 on day

7

3 to .7 on day 5), was found to be associated with the period of most
intense immunological graft destruction (Tilney et al., 1986).

In

addition, specific, MHC-restricted allograft rejection in vivo by
cloned CTLs has been reported (Snider et al., 1986).
Mditional Cell Types Affected b/ IL-2
In addition to its effects on T cells, IL-2 can promote the
activation of other cells associated with,
rejection of allografts.

or involved in,

the

Activated B cells express the high affinity

IL-2R (Waldman et al., 1984) and IL-2 promotes both proliferation and
differentiation of B cells.
production of antibodies

Furthermore,

IL-2 regulates B cell

(Jelinek and Lipsky,

1987).

At

high

concentrations, IL-2 has been shown to enhance cytotoxic activity in
macrophages (Malkovsky et al., 1987).

Similarly, NK cells respond to

IL-2 with augmented cytotoxic activity,

IL-2 receptor expression,

proliferation and increased interferon gamma production (Trinchieri et
al.,

1984;

Brooks

and Henney,

1985;

Malkovsky

et

al.,

1987).

Together, these findings indicate multiple regulatory effects of IL-2
on immune function.
A role for NK cells and/or macrophages in graft rejection has
not

been

elucidated.

While

they do

exist

as

somewhat minor

populations in cellular infiltrate of rejected grafts (Haryry et al.,
1984; Tilney et al., 1984), their significance is not understood.
Macrophages participate in cell mediated immunity by

interacting

specifically with lynphocytes to promote antigen-specific responses,
by

their

ability

to phagocytize

cells

antibodies and fcy direct cytotoxicity

specifically

labeled

(Anderson and Hill,

fcy

1988).

8

Similarly, NK and killer cells are capable of cytolytic activity
mediated fcy antibodies.
Suppressor Cells
While atterrpts to maintain allografts have focused mainly on
procedures that might interfere with or reduce effector cell function,
an

alternate method might

suppressor cells.

be

through

the

induction

of

imnune

Results of various methods used to identify

suppressor cells have implicated both T and B lynphocytes (Katz et
al., 1974; Zubler et al., 1980) as well as macrophages (Baird and
Kaplan,

1977; Oehler et al.,

1977)

as mediators of

suppression.

However, overwhelming evidence .indicates that T cells, specifically
CD8+ cells, are responsible for most suppressor cell activity.

When

CD8+ cells were added to mixtures of B cells and T helper cells,
antibody production was substantially reduced (Hodes, 1989).
been suggested that suppressor cells
regulators

of

immune

responses

serve more

than

as

mediators

It has

homeostatic
of

complete

unresponsiveness (Eardley and Gershon, 1975; Eardley et al., 1978).
Such

regulatory

mechanisms

acceptance and/or rejection.

could

be

associated

with

allograft

Antigen non-specific T suppressor cells

have been identified during graft-versus-host disease following bone
marrow transplantation

(Pickel

and Hoffmann,

1977;

Shearer

and

Folisson, 1980), indicating a role for these cells in failed grafts.
There is also evidence for suppressor cell involvement in the fetal
allograft phenomenon and these studies will be discussed in the
following sections.

Unfortunately, even with the tremendous quantity

of information pertaining to suppressor cells, the basic mechanism
underlying the functions of such cells remains largely unresolved.
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In Vitro Assessment of Immune Cell Function
Mitogen-stimulated Proliferation
While lymphocyte activation generally requires stimulation by
antigen in the context of MHC, there are reagents available that
obviate the need for specific antigen stimulation.

These reagents

include lectins or mitogens which can polyclonally activate cells by
binding non-specific carbohydrate groups on the lynphocyte surface
(Sharon, 1983).

Plr/tohemagglutinin (PHA) (Nowell, 1960), concanavilin

A (Con A) and pokeweed mitogen (PWM) were among the first lectins
identified.

The ability of Con A and PHA to selectively stimulate T

cells is likely due to their binding of carbohydrate groups expressed
on T cell receptors (Sharon, 1983).

In fact, results from recent

studies indicate the lectins bind directly to components of the T cell
receptor (Weiss et al., 1987).

In contrast to these T cell mitogens,

EWM primarily stimulates B cells while also affecting T
Lipopolysaccharide

(LPS)

endotoxin also

serves

effectively

cells.
as

a

mitogen, but it non-specifically stimulates B cells to proliferate,
differentiate and produce antibodies

(Kincade and Girrtole,

1989).

These potent lymphocyte stimulators have facilitated the study of non
specific immune cell responses in vitro.
Mixed Lvmohocvte Reaction
Another in vitro assay that has been extensively used to
investigate cell mediated immune responses is the mixed-lynphocyte
reaction (MLR). This assay exploits the fact that T cells recognize
non-self MHC antigens as foreign,

and

the

stimulation ty

this

"foreign" antigen causes the cells to undergo transformation and
proliferation.

Because of this blast response by lymphocytes to
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allogeneic stimuli, the assay has been referred to as the in vitro
correlate of allograft rejection (Andersson and Hayry, 1974).

Cell

proliferation in this assay can be assessed ty measuring cell uptake
of a radiolabeled precursor supplemented to the culture medium.

Due

to the nature of the cellular response in this assay, it has been used
for tissue typing (Roit, 1987) and is still frequently used to assess
the relatedness of two individuals.

In addition, MLRs have been used

to identify suppressor activity of immune cells obtained from the
placenta (Uren and Beyle, 1990) and to assess soluble suppressor
factors found in conceptus culture medium (Murray et al., 1987).
Cvtolvtic Cell Assays
The ability to measure cytolytic activity of cytotoxic T cells
ty using target cells that have incorporated 5^Cr, released and
measurable upon lysis of that cell, provides another mechanism that
can be used when examining antigen-specific,
responses in vitro.

cell-mediated immune

Such an assay is particularly relevant in studies

of allograft rejection because of the involvement of CTL in this
response.

In contrast to the cytolytic assay, a CTL proliferation

assay is used to quantify IL-2.

Due to the potent effect of IL-2 on

CTL proliferation, it was possible to establish a murine cytolytic T
lynphocyte

line

(CELL)

for

measuring

IL-2.

These

CTLL

cells

constitutively express the high affinity IL-2R and proliferate only in
response to IL-2.

In the absence of IL-2,

proliferate and die within 12-18 hours.

the cells cease to

Even more important, the

degree of CTLL proliferation is dependent on the concentration of IL2.

Therefore, quantitative measurements of IL-2 activity in various

samples can be determined with these cells (Gillis et al., 1978).
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THE

PUTATIVE

IMMUNO-PROTECTIVE

ROLE

OF

THE

PLACENTA

The Phenomenon of the Fetal Allograft
Mammalian

pregnancies

are

generally

characterized

by

the

successful development of allogeneic conceptuses intimately associated
with maternal uterine tissue.

Maternal acceptance of the fetal

allograft represents a unique case of immunological tolerance that is
consistently

reproducible.

For

decades

scientists

have

been

challenged to explain how the feto-placental unit survives to term
while artifactual allografts repeatedly fail.
In 1953, Medawar offered potential solutions to the rrystery.
Based

on

his

solutions,

Billingham

(1964)

and

Simoons

(1969)

formulated hypotheses pertaining to the mechanisms possibly involved.
The proposed mechanisms included: 1) The uterus is an immunologically
privileged site 2)

The conceptus is antigenically immature 3)

The

placenta provides a barrier to cellular and humoral maternal-fetal
interactions 4) The maternal immune system is suppressed and 5) The
immune response of the mother is qualitatively different during
pregnancy such that it promotes fetal survival.

The first option has

been eliminated (Beer and Billingham, 1976) since it has been shown
that the uterus possesses an immune system capable of tissue-graft
rejection (Reimers and Dzuik, 19 7 4 ) .

There is substantial evidence

against the second option as the conceptus expresses several classes
of alloantigens and isoantigens on its cell surfaces (Wegmann et al.,
1979; Chatterjee-Hasrouni and LaLa, 1982; Lala et al., 1983; Johnson,
1984; Crunp et al., 1987; Donaldson et al., 1990).

Furthermore, the

presence of anti-fetal antibodies frequently identified in maternal
circulation, refute both options 2 and 4

(Terasaki et al., 1970;
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Newman and Hines, 1980; Smith et al., 1982; Antczak et al., 1984).
Finally, there is a complete lack of evidence supporting option five.
The potential role of the placenta as

the primary

barrier

to

immunological rejection (option 3) has increasingly received greater
attention with

the

accumulation of

evidence against

the

other

hypotheses.
The Equine Placenta
The term "placental barrier" has long been used to describe the
tissue layers separating fetal and maternal blood supplies.
of

the placenta

as

a

"barrier"

physiologically between species.

differs both

The role

structurally

and

Equine placentae, in particular, are

characterized ty specialized structures with functions unique to the
species.

Because the research described in this dissertation focuses

largely on the horse conceptus, a brief description of implantation
and placental formation in this species is warranted.
Oviductal transport in the mare appears to be selective for
fertilized embryos, and oocytes are only rarely found in the uterus.
Horse embryos enter the uterus as early blastocysts on day 5 or 6
after ovulation (Hamilton and Day , 1945; Oguri and Tsutsumi, 1972).
Normally developing embryos hatch frcxn their zonae pelucidae on day 8
or 9, but remain encapsulated ty another non-cellular, translucent
membrane referred to as the embryonic capsule (Flood and Betteridge,
1982).

Trans-uterine migration of the embryonic vesicle ceases hy day

15 when fixation occurs in one of the uterine horns (Ginther, 1986).
Vesicle

expansion

and

fetal

development

proceed,

but

actual

implantation does not begin until day 36 of gestation (Allen et al.,
1973).
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Placentation

in

equids

is

uniquely

characterized

formation of structures known as endometrial cups.

ty

the

These cups

originate from specialized trophoblast cells, chorionic girdle cells,
which invade the maternal endometrium between days 36 and 38 after
ovulation (Allen and Moor, 1972; Allen et al., 1973).

Within 24

hours, these cells migrate into the uterine stroma, increase in size
and begin secreting equine chorionic gonadotrophin (eCG). Leukocytes,
primarily lymphocytes, immediately accumulate around the developing
endometrial cups and their numbers increase as gestation progresses
(Allen, 1979).

While these cells appear to "wall off" each cup from

the uterine stroma, it is not until day 70 or 80 that the lymphocytes
invade the cups.

This invasion of immune cells leads to the

destruction of the endometrial cups and ty day 120, the tissue sloughs
into the uterine lumen.
The nature of the intense lymphocyte accumulation surrounding
the endometrial cups remains unclear.

A similar response is not

observed around the non-invasive trophoblast of the allantochorion
(Allen, 1975) indicating that cup cells may express antigens not
present on other trophoblast cells.

The fact that antibodies to fetal

major histocompatibility complex (MHC) antigens are present in 90% of
mares carrying MHC-incompatible fetuses (Bright et al., 1978; DeWeck
et al., 1978), and that these antibodies are detected 2 to 4 weeks
after cup formation

(Antczak et al.,

1984)

would indicate that

paternal MHC-antigens are present on endometrial cup cells.

Indeed,

Crump et al. (1987), provided conclusive evidence for the expression
of paternal MHC antigens on the invasive chorionic girdle cells at day
33 of gestation.

In addition, Donaldson et al.

(1990), found that

14

class I MHC antigen expression was largely restricted to the early
stages of trophoblast invasion.

They reported a reduction in MHC

antigens on mature cup cells and suggested that developnentally
regulated MHC expression may serve as one defense against alloirrmune
rejection mechanisms.

Surely, this phenomenon supports the suggestion

that the placenta plays a role as an iranuno-protective barrier for the
fetal allograft.

Conversely, a vigorous leukocyte reaction against

MHC-compatible endometrial cups has been observed (Allen et al., 1983 ;
Antczak and Allen,

1984)

indicating that MHC

antigens

are

not

primarily responsible for the immune response against endometrial
cups.
Hybrid and Interspecific Pregnancies
The study of both successful and failed hybrid and interspecific
pregnancies, has led to a greater appreciation for the placenta's role
in preventing immunological rejection of the fetus.

The three most

thoroughly studied models of hybridism are the murine model of
musculus and M.

Mjs

caroli, the equine model involving primarily the

domestic horse and donkey and a model involving two genera,

the

domestic sheep (Ovis aries) and goat (Capra hircus). While exhibiting
sane similarities, each model is unique with respect to success rates,
complications

and

characteristic

intraspecific pregnancies.
involved in,

abnormalities

relative

to

Immunological interference appears to be

if not responsible

interspecific pregnancies, tut
manifested differs with species.

for,

how

anomalies

this

iranune

associated with
interference

is
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The Marine Model
The murine model of interspecific pregnancy has been intensively
studied (Rossant et al., 1982; 1983a and Crcy, 1985).

While M. caroli

and M. musculus have the same diploid chromosome number they do not
readily hybridize.

Both fertilization and postinplantation survival

rates are extremely low (West et al., 1977), but such failure likely
results from retarded development of hybrids relative to either
parental species (Frels et al., 1980).

Such retarded development

indicates genomic incorrpatibility and not immunological interference
as the primary cause of pregnancy failure, and will therefore not be
discussed further.

Results from interspecific embryo transfer between

the two murine species have revealed a more puzzling situation.
Survival to term of M. caroli embryos transferred to M. musculus
recipients was very low (1/69) while M. musculus embryos transferred
to the same recipients developed normally
Furthermore,

Cray et al.

(1982)

(Frels et al.,

noted that

after

9.5

1980).

days

of

apparently normal development, the M. caroli placental trophoblast
layer became infiltrated with lymphocytes and hemorrhage occurred,
while M. musculus embryos in the
Cytotoxic T lymphocytes that
identified

at

the

same uterus

lysed M.

resorption

sites

were unaffected.

caroli target cells were
indicating

involvement in the demise of M. caroli embryos.

irrmunological

Additional evidence

for immunological involvement in fetal survival was reported by Clark
et

al.

(1983)

immunosuppressive

who

found

capabilities

that
are

while
present

decidual
during

cells

with

intraspecies

pregnancy in one uterine horn, they are not detectable in decidua of
xenogeneic (M. caroli) conceptuses that have implanted in the opposite
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uterine horn.

It was hypothesized that M. caroli trophoblast failed

to recruit or stimulate these suppressor cells.
The

fact that the conceptus represents

a unique

type

of

allograft is supported ty the results of experiments involving the
transfer of

M.

caroli

embryos

to M.

musculus recipients

genetically or experimentally altered immune function.

M.

with
caroli

survival in M. musculus females was not improved when recipients were
treated with Cyclosporin A which is capable of inhibiting T-lymphocyte
mediated rejection of transplants (Cray et al., 1985b).

In the same

study, M. musculus recipients that were either athymic

(T cell

deficient) or natural killer (NK) cell deficient failed to support M.
caroli embryo development, yet the athymic recipients did accept M.
caroli skin grafts.

While these data may refute the hypothesis of

immune system involvement with interspecific pregnancy failure in this
model, the results are complicated ty the confounding effect of immune
system alterations on pregnancy in general.

Difficulties were

reported maintaining pregnancies in athymic M.

musculus

females

following the transfer of M. musculus embryos (Cray et al., 1985b).
The failure of putatively immuno-incompetent M. musculus mice to
support M. caroli embryos has been explained as a result of M.
musculus

hypersensitivity

(pre-existing

antigens (Clark et al., 1986).

immunity)

to

M.

caroli

However, the basis for this pre

existing sensitivity was not given.
Why interspecific pregnancies proceed

successfully when M.

musculus embryos are transferred to M. caroli recipients, yet fail
consistently when the species of embryo and recipient are reversed,
remains unclear.

It has been reported that fewer suppressor cells are
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present in the decidua of M. caroli conceptuses than M. musculus
conceptuses during intraspecific pregnancies (Clark et al., 1986).

In

addition, M. caroli placental cells exhibited less inherent ability to
inhibit cytotoxic effector cell killing when compared to M. musculus
placental cells.

In view of this data, it has been suggested that,

compared to M. musculus, M. caroli conceptuses have a weakened defense
against maternal immune attack even in the M. caroli uterus (Anderson,
1988).

Even with the substantial quantity of information obtained,

the exact mechanism responsible for the failure or success of M.
musculus/M. caroli interspecific pregnancies has not been defined.
However, it is widely believed that a maternal immune response and a
failure

of

conceptus-derived

local

immunoregulation

are

primary

contributors to the death of xenogeneic embryos.
The Sheep/Goat Model
Scientists have been puzzled for years over the failure of
domestic sheep x goat hybrid pregnancies when the two species are
frequently observed mating.
initially

suggested

as

Interspecific fertilization failure was

an

explanation

for

failure

of

hybrid

pregnancies, tut this theory was refuted long ago (Warwick and Berry,
1949; Bratanov and Dikov, 1962).

Despite the fact that fertilization

between sheep and goats does occur, hybrid embryos invariably die
during the first 2-3 months of gestation (Warwick and Berry, 1949;
Alexander et al., 1967).

Death does not appear to be caused ty

cytological anomalies associated with altered
(Buttle and Hancock, 1966).

chromosome

numbers

In addition, Hancock and Jacobs (1966)

found no evidence of developmental abnormalities that might explain
early death.

It was suggested that because the caprine placenta
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differs from that of the ovine in that it is not a source of
progesterone (Amoroso and Perry, 1975), the hybrid placenta may prove
to be deficient in progesterone production.

Such a hormone deficiency

could lead to endocrine-associated pregnancy

failure.

However,

McGovern (1976) was unsuccessful in extending the survival of the
hybrid fetus ty administering exogenous progesterone to recipient
does.
While all of the factors mentioned above may contribute to sheep
x goat hybrid pregnancy loss, there is an overwhelming body of
evidence which suggests that pregnancy failure is due to irrmunological
incompatibility between maternal and fetal tissues.
of

abnormal

histological

and

ultrastructural

Numerous reports

characteristics

of

placentae in hybrid pregnancies (Alexander et al., 1967; Hancock et
al., 1968; McGovern 1973a; Dent et al., 1971a,b) support the idea that
the maternal inmune reaction is directed against the hybrid placenta
and not

the

fetus

itself.

Hybrid

placentae

extensively studied by Hancock et al., 1968.
sane pregnancies the fetal membranes

development

was

They reported that in

failed to establish normal

contact with the uterus and caruncular development was incomplete. A
similar deficiency in trophoblast invasion has been reported following
the transfer of sheep embryos to goat recipients

(Hancock et al.,

1968).

In either case, fetal death results. By contrast, in other

hybrid

pregnancies

and

when

goat

embryos

developed

in

sheep

recipients, cotyledonary development was prominent and invasion of
uterine tissue by trophoblast was extensive.

In such cases, necrosis

of both fetal and maternal tissues occurred, acconpanied by maternal
immune cell infiltration.

Large aggregation of platelets and lobular
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swelling of the endothelium were identified in maternal capillaries
beneath

the

uterine

epithelium.

Similar

observations

are

characteristic of viscera undergoing rejection and of blood vessels
damaged by antigen-antibody complexes. The fact that hybrid pregnancy
failure occurs earlier during gestation in second-time recipients or
in recipients immunized with xenogeneic paternal leukocytes, supports
the theory that an immunological reaction is the primary factor
resposible for hybrid fetal death (McGovern, 1973).

TJhg-Jming_Matel
Equidae are unique in that hybrid and interspecific pregnancies
are possible across a variety of species with wide chromosomal
differences
Nevertheless,

(Short

et

relative

al.,
to

1974;

Benirshke

intraspecific

and

Ryder,

pregnancies,

1985).

there

are

significant alterations in endometrial cup formation and survival, eCG
secretion and leukocyte accumulation
pregnancies.

in

interspecific

or hybrid

Results from numerous studies indicate that the immune

system is primarily responsible for aberrant cup formation.
The transfer of horse embryos to donkey recipients appears to be
more successful than the transfer of donkey embryos to horses.
Compared

to

intraspecific

donkey

pregnancies,

pregnancies result in the formation of

larger

horse-in-donkey
endometrial

cups

surrounded by excessive numbers of accumulated leukocytes (Allen et
al., 1985).

Despite the increased number of leukocytes, the cups

remain intact past day 100 of gestation and pregnancy proceeds
successfully.

In contrast, donkey embryos develop normally in horse

recipients up to day 70 despite a complete lack of endometrial cup
formation.

Thereafter,

they succumb to a vigorous cell-mediated
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maternal immune response directed against the allantochorion.

Similar

to observations of horse-in-donkey pregnancies, are reports of hinny
pregnancies (female donkey bred to male horse) in which there are an
excessive number

of

leukocytes

surrounding

the

highly

invasive

endometrial cup tissue yet the cups maintain a normal lifespan of 80
to 100 days (Allen, 1982b).

In contrast, mule pregnancies (female

horse bred to male donkey) are characterized ty intensive lymphocyte
infiltration deep into the endometrial cups Which results in complete
loss of cup tissue ty day 60 of gestation (Allen et al., 1982b).
Surprisingly, mule pregnancies are successful despite the early loss
of endometrial cup tissue.
Various therapies have been used in hopes of promoting the
successful

maintenance

of

donkey-in-horse

pregnancies.

Daily

administration of a synthetic progestin to mares with donkey fetuses
failed to prevent pregnancy failure (Allen 1982b; Allen et al., 1985).
Injections of partially purified eCG obtained from mares carrying
intraspecific pregnancies also proved to be mostly ineffective in
prolonging

donkey

pregnancies

in

mares.

However,

a

dramatic

improvement in such pregnancies was observed when recipient mares were
immunized with parental donkey lymphocytes (Antczak and Allen, 1984).
Allen et al. (1987) went on to find that such an immunization regimen
was successful even if the lymphocytes were not of parental origin.
Based on the results of donkey-in horse pregnancies, it has been
proposed (Antczak and Allen, 1984; Allen et al., 1985) that antigens
on

the

invading

chorionic

girdle

cells

stimulate

a

maternal

immunoprotective response and if cup formation fails, the response
remains unsolicited and immune rejection proceeds.
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Exotic Intersoecies Pregnancies
The phenomenon of interspecific and hybrid pregnancy is not
limited to domestic species.

As stated previously, there are a number

of viable equine hybrids.

One example is the Przewalski

{Equus

przewalski, 2n=66) x domestic horse (E. caballus, 2n=64) hybrid.

The

success of this cross led to embryo transfer attempts from endangered
przewalskis to domestic mares (Hearn and Sumners, 1986; Sumners et
al., 1987).

Mary of

the

established interspecific pregnancies

developed to term and the presence of cytotoxic antibodies to parental
antigens, as well as normal eCG levels in maternal sera, indicated
normal endometrial cup formation.

Perhaps more surprising is the

successful transfer of Grant's zebra (E. burchelli, 2n=44) embryos to
domestic horses (Bennet and Foster, 1985; Kydd et al., 1985; Hearn and
Sumners et al., 1986; Sumners et al., 1987).

Transfer of Grant zebra

embryos to donkey recipients was also attempted (Kydd et al., 1985;
Hearn and Sumners, 1986; Sumners et al., 1987) and pregnancies were
established, but no live young were bom.
fetus

at

day

292

of

pregnancy

and

One animal aborted her
exhibited

iirrnunologically based pregnancy toxemia syndrome.

symptoms

of

Pregnancy failure

in the other recipients was characterized by very low levels of eCG
produced for only a brief period of time suggesting poor endometrial
exp formation and a strong cell-mediated cytotoxic reaction.
Among Bovidae there have been viable hybrid offspring produced,
one example being the Zebu cattle (Bos indicus) x European domestic
cattle (B. taurus) cross (Summers et al., 1983b).
American bison

(Bison bison)

In addition, the

will hybridize with European bison

{Bison, bonasus), B. indicus, B. taurus and the Yak (Bos grunniens).
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Bovidae

interspecific

and

intergeneric

pregnancies

established

following embryo transfer have yielded variable results.

A pregnancy

resulting from the transfer of a B. taurus embryo to a water buffalo
was aborted ty 3 months of gestation and no

(Bubalus bubalus)

pregnancies resulted from reciprocal transfers (Drost et al., 1986).
Stover et al. (1981) reported the birth of a viable gaur calf (Bos
gaurus)

to a domestic cow recipient

(23. taurus)

following embryo

transfer, however the other four recipients lost their pregnancies
prior to term.

In addition, the authors of this study reported

abnormally low numbers of cotyledons on the allantochorion of both
successful and aborted pregnancies indicating inappropriate placentaluterine tissue interaction.

In contrast, reports of failed Dali's

sheep (Ovis dalli dalli) pregnancies established following embryo
transfer to domestic sheep (0. aries) indicated that there were no
significant differences in cotyledon numbers (Buckrell et al., 1990).
As there does not appear to be a specific characteristic associated
with interspecific pregnancy failure, it has been difficult to predict
and/or explain the success or failure of such pregnancies.
most,

if

not

all

cases

of

interspecific

immunological involvement is implicated.

pregnancy

Nevertheless,

However in
failure,
the

few

successful exotic-in-domestic species pregnancies as well as the
successful transfer of embryos between two exotic species such as the
bongo antelope (Tragelaphus euryceros) to African eland

(T.

oryx)

(Dresser et al., 1985) maintain interspecific embryo transfer as a
potentially

viable

endangered species.

option

for

facilitating

the

propagation

of
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Embryo Manipulation
Perhaps the most convincing evidence supporting the hypothesis
that the placenta is responsible for fetal allograft survival has been
obtained from studies involving pre-implantation embryo manipulation.
As embryos develop from morulae to blastocysts, the first irreversible
cell differentiation occurs and two distinct cell lineages emerge, the
inner-cell-mass (ICM) and the trophectoderm.

The ICM cells continue

to differentiate and become specialized, eventually completing the
formation of the fetus.

The trophectoderm, or trophoblast cells,

possess the inherent ability to initiate implantation (Gardner et al.,
1973) and placental tissue is derived almost entirely from these
cells.
In 1961, Tarkowski first reported that viable offspring could be
produced from composite embryos derived from two aggregated eight-cell
stage mouse embryos.

Such offspring, containing cell populations of

more than one genotype, are commonly referred to as chimeras.
the past several years,

Over

a great deal of progress has been made

concerning embryo manipulation.
than ty embryo aggregation,

Methods for producing chimeras, other
were identified.

For example,

the

blastocyst injection technique was described by Gardner et al. (1973)
and later simplified ty Butler et al. (1987).

This procedure involves

the injection of an ICM isolated from one blastocyst into a recipient
blastocyst.

The end result is generally a chimeric fetus surrounded

ty non-chimeric trophoblast.
Using blastocyst injection, Rossant and Frels (1980) injected M.
caroli ICMs into M. musculus blastocysts and healthy, viable chimeric
offspring were produced in M. musculus recipients.

As this procedure
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ensured that the trophoblast, and thus the placenta, was derived from
M. musculus cells, the recipients were prevented from immunologically
rejecting the M. caroli cells contributing to the fetus proper.

The

importance of the trophoblast in maintaining interspecific murine
pregnancies was further clarified when Rossant et al. (1982b) reported
that the injection of M. musculus ICM into M. caroli blastocysts did
not result in viable chimeric offspring if these composite embryos
were transferred to M. musculus recipients.

In addition, Papaioannou

(1981) used a procedure known as blastocyst reconstitution, whereby
the ICM of one blastocyst is completely replaced ty the ICM of
another, to produce a M. caroli offspring surrounded ty M. musculus
trophoblast carried to term in a M. musculus recipient.

For fetal

allograft survival, it appears to be imperative that the trophoblast
and recipient are of the same species.
The success of chimeric and interspecific pregnancies following
embryo manipulation is not restricted to the murine species.

Such

procedures have been applied to pre-implantation sheep and goat
embryos over the past several years with results similar to those
reported for mice.

A number of scientists have produced interspecific

sheep <-> goat chimeras ty aggregating cells from both sheep and goat
embryos (Fehilly et al., 1984) and ty blastocyst injection (Fehilly et
al., 1984; Polzin et al., 1986, 1987; Roth et al., 1989).

In most

cases, the manipulations were carried out in a manner that favored the
development of trophoblast from cells of the same species as the
recipient.

However, it is worth noting that in cases of failed

chimeric pregnancies, interspecific chimeric trophoblast was suspected
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and placental

formation was

characterized ty

fewer

placentomes

(Anderson, 1988).
Blastomere aggregation and ICM injection are two techniques that
have

been

used

pregnancies.

successfully

in

promoting

true

interspecific

By combining blastomeres from embryos at

slightly

different stages of development, such that the ICM is derived mainly
from one embryo and the trophoblast from the other, both goat-in-sheep
(Meinecke-Tillman and Meinecke, 1984) and sheep-in-goat (Fehilly and
Willadsen, 1986) pregnancies have teen carried to term.

Similarly,

interspecific injections of sheep ICM into goat blastocysts or goat
ICM into sheep blastocysts have occasionally resulted in non-chimeric
lambs b o m to goats and kids b o m to sheep (Fehilly et al., 1984;
Polzin et al., 1987).

Furthermore, the injection of sheep x goat

hybrid ICM into sheep blastocysts followed ty their transfer to sheep
recipients has resulted in sheep x goat hybrid <-> sheep chimeras
(Roth et al., 1989).

These results indicate that sheep x goat hybrid

cells are viable and can contribute to the fetus and that hybrid
pregnancy

loss

likely

results

from

improper

uterine-placental

interactions, not aberrant fetal development.
While the significance of the placenta in protecting the fetal
allograft is becoming well-established, the mechanism through which
protection is mediated remains unclear.

The theory that the placenta

"masks" foreign fetal antigens from maternal immune recognition is
flawed in that antibodies to fetal antigens are detected in the
circulation of pregnant females.

More specifically, antibodies to

both allogeneic and xenogeneic antigens have teen identified in sheep
and goats carrying interspecific, chimeric pregnancies

(Ruffing et
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al., 1988).

Even when ICM injection techniques are used such that

non-chimeric

trophoblast

is

ensured,

the

mother

recognizes

and

responds, at least via humoral immunity, to xenogeneic fetal antigens
(MacLaren et al., 1990).
Pertinent information concerning the irrsnuno-protective role of
the

placenta

has

been

obtained

from

studies

of

hybrid

and

interspecific pregnancies as well as from experiments involving embryo
manipulation.

Despite the progress that has been made, there is no

definite single answer to the proposed question concerning fetal
allograft survival.
complex,

Most

likely,

the mechanism responsible

involving specific placental,

is

uterine and immune system

interactions that will require years of study to fully understand.

IMMUNOSUPPRESSION

AND

PREGNANCY

Antibody Involvement
Following the establishment of immunoconpetency in pregnant
fatales and the detection of maternal immune responses generated
against fetal antigens, stronger interest was expressed in the theory
that an immunosuppressive mechanism localized at the feto-matemal
interface is responsible for fetal allograft survival.
of anti-fetal antibodies in serum of pregnant
discussed.

The presence

fatales has been

The capacity of the placenta to act as an antigen-

expressing "sponge" for absorbing these antibodies has been suggested
(Raghupathy et al., 1981; Raghupathy et al., 1984), tut Bell and
Billington (1983) found that the "sponge" activity of the placenta was
ineffective

when

serum

contained

higher

antibody

titers.

Alternatively, it has been suggested that anti-patemal antibodies
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which accumulate in and around the placenta (Hunziker et al., 1986)
act as blocking antibodies.

Such antibodies obtained from parous

serum (Pavia and Stites, 1981; Hellstrom and Hellstrom,

1975)

or

eluted directly from the placenta (Bonneau et al., 1973; Faulk et al.,
1974; Stewart et al., 1984) are capable of suppressing lyrrphokine
secretion, mixed lynphocyte reactions, and the generation of cytotoxic
killer cells in vitro (Rocklin et al., 1979).

However, the relevance

of these blocking antibodies is questionable in light of the fact that
not all successful pregnancies are associated with a humoral immune
response (Lala et al., 1983) and thus, perhaps more important for
fetal allograft survival, is a local suppression of cell-mediated
immunity.
Suppressor Cells
Localized

down-regulation

of

maternal

cell-mediated

immune

responses could occur via recruitment/activation of suppressor cells
or ty the production of soluble immunosuppressive factors.

Supporting

evidence for the former has been reported ty Clark and colleagues who
have identified suppressor cells in uterine draining lymph nodes and
decidual cells scraped from the gravid uterus (Clark et al., 1980).
Two different populations have been identified as phase A and phase B
cells (Slapsys and Clark, 1983).

The phase A cells are produced in

response to hormonal changes and prevent the generation of cytotoxic T
lymphocytes (CTLs), but are only present during the preimplantation
phase of gestation (Clark et al., 1980; Brierley and Clark, 1985).
Phase B suppressor cells are described as non-T, non-B lymphocytes
produced only when viable trophoblast is present.

The absence of

these cells is associated with failed Mus musculus x AT. caroli hybrid
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pregnancies (Clark et al., 1980; Clark et al., 1983).

Phase B cells

express antigen-non-specific suppressor activity which inhibits T cell
activation in response to IL-2 (Clark et al., 1985).

While these two

types of suppressor cells may play an important role at the fetomatemal interface, their activity can be mediated ty a soluble factor
of the decidua (Clark et al., 1984), indicating that the suppression
of cell-mediated immunity in the uterus may ultimately be attributed
to soluble factors produced ty the trophoblast.
Macrophage Involvement in Immunosuppression
While many investigations have focused on lymphocytes as the
target cell type for soluble immunosuppressors derived from the
conceptus, there is some evidence that macrophages also play a role in
suppressing immune reactivity in and around the placenta.

Uren and

Beyle (1990) recently reported that macrophages isolated from human
placentae elicited only a low proliferative response from allogeneic T
cells and failed to incite OIL function.

The suppressive effect of

these macrophages was not inhibited ty indamethacin, indicating the
activity was independent of prostaglandin production.

These results

differ from those reported ty Scodras et al. (1990) who found that, in
the mouse,

decidual

macrophages

inactivated NK

cells

ty

their

production of FGE2 .
Suppressor Activity of Prostaglandins and Hormones
It has been well established that prostaglandins, especially
PGE2 , are effective immunosuppressors.

PGE2 is a feedback inhibiter

of cellular immune functions and is produced ty suppressor cells
(Goodwin and Ceuppens, 1985).

Although PGE2 is produced in culture by

embryos of numerous species including humans (Holmes et al., 1990),
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cows (Brang et al., 1988), sheep (Lacroix and Karin, 1984) and rabbits
(Pakrasi and Dey, 1982), its role at the feto-matemal interface as a
product of conceptus tissue is not well defined.
More attention has been focused on the potential significance of
conceptus-derived, hormone-mediated suppression of immune function.
Specifically, two steroid hormones, progesterone and estrogen, which
play a critical role in the maintenance of pregnancy and are produced
ty the conceptus (Heap et al., 1982; Dickmann et al., 1976; Flood et
al., 1979) have been studied for their iimmoregulatory capacities.
In 1953, Black et al. first reported a decreased resistance to
infection in the pseudopregnant rabbit uterus as corrpared to that of
the estrus rabbit.

However,

it was many years later that truly

compelling evidence for progesterone as a uterine immunosuppressant
was reported.

Moriyama and Sugawa (1972) demonstrated that, following

progesterone treatment, xenogeneic cell survival in the hamster uterus
was prolonged.

Similarly, Siiteri et al.

(1977) inplanted steroid

containing silastic inplants into murine uteri and found that such
treatment resulted in a local suppression of immunity and prolongation
of

xenogeneic

skin

grafts.

In

addition

to

these

in

vivo

investigations, numerous in vitro studies have been carried out to
characterize the immunoregulatory activity of
general,

progesterone.

In

the results indicate that progesterone inhibits mitogen

activation of T lymphocytes when present in concentrations ranging
from 10-20 jJM or greater (Shiff et al., 1975; Mendelsohn et al., 1977;
Mori et al., 1977; Clemens et al., 1979), it inhibits T cell response
to allogeneic cells in a MLR (Clemens et al., 1979) and can block the
generation of CTLs directed against MHC antigens (Pavia and Stites,
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1981) when present at 1 to 3 fig/ml.

However, progesterone can not

affect CTL activity once the cells are produced, and progesterone is
lethal to cells at 20 fig/ml

(Siiteri and Stites,

1982).

The

significance of progesterone as a local irrmunosuppressor in utero is
questionable considering only picogram-nanogram

concentrations

hormones are secreted ty the conceptus in culture or

of

found in

blastocoelic fluid of embryos (Flood et al., 1979; Marsan et al.,
1987).
Estrogen has received much less attention as an immunoregulatory
factor,

partly because

contingent on several
suppressor

or

an

its

effect

factors.

enhancer

of

on

immune

cell

function

Estrogen can act

as

immune

depending

function

either

is
a
on

characteristics of the host, such as age (Reilly et al., 1967), genome
(Stem and Davidsohn, 1955), species (Nelson et al., 1967) and timing
of immunization (Feigen et al., 1978).

While results from in vitro

studies with human lymphocytes have demonstrated the capacity of
estrogen to suppress mitogen, antigen or allogeneic cell activation,
as with progesterone, the levels of estrogen required were far above
physiological concentration

(Mendelsohn et al., 1977; Neifeld and

Tormey, 1979).
Soluble Suppressor Factors
Murine
The soluble placental factor responsible for inducing suppressor
T cells during murine pregnancies was first partially characterized hy
EXitchet-Suchaux et al.

(1979).

In 1984,

Chaouat and Chaffaux

reported that this factor, known as the Suppressor Inducer Factor
(SIF), could induce suppressor cells in the Graft-vs-host reaction.

31

Similar suppressor activities have been identified in supernatants of
cultured murine blastocysts (Mayumi et al., 1985).

Furthermore, it

has been shown that supernatants from murine decidua can block mixed
lynphocyte reactions (Chaouat and Kolb, 1984) and have effectively
enhanced the survival of a murine heart allograft (Chaouat, 1987).
In addition to SIF, other irrmune modulatory factors associated
with murine pregnancy have been identified.

The resistance of

placental tissue to lysis by natural killer cells and cytotoxic T
lymphocytes

is

associated with

the production of

two

distinct

molecules that inhibit NK and CTL activity (Chaouat et al., 1985).
There is evidence that NK cell infiltration into the decidua is
associated with spontaneous abortion following matings of CBA female
mice with DBA/2J males (Gendron and Baines, 1988).

These findings may

indicate a requirement for inhibiting NK cell activity to maintain
successful pregnancies.
While placental-derived suppressor factors may be ultimately
responsible for locally inhibiting the irrmune response in the uterus,
they may be acting indirectly through the activation of suppressor
cells responsible for suppression of cell-mediated irrmunity.

The

suppressor cells obtained from murine decidua secrete a 100,000 dalton
factor that, in turn, blocks the response of T cells to IL-2 (Clark et
al., 1985; Clark et al., 1986).

In summary, murine decidua and/or

conceptuses produce soluble factors that regulate immune suppressor
cells.

These cells produce soluble factors capable of interfering

with cell-mediated irrmune responses.
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Human
While the murine species has been used most extensively in
studies of placenta-derived, immunoregulatory molecules, a substantial
quantity of information is available concerning similar factors in the
human.

Decidual cells obtained from endometrium of first trimester

human pregnancies suppressed lynphocyte responses when supplemented to
MLR cultures (Nakayama et al., 1985).

In addition, the production of

immunosuppressor factors ty pre-implantation embryos fertilized in
vitro has been reported

(Daya and Clark,

1986).

These authors

suggested that the detected production of suppressor factors from only
43% of the embryos could, in part, explain the high percent of embryos
lost very early in pregnancy.
Two suppressor factors associated with pregnancy in humans have
received considerable attention.

A specific factor known as placental

protein 14 (PP14) was isolated from term human placentae in 1982 ty
Bohn et al. and has since been shown to inhibit allogeneic MLR (Bolton
et al., 1987) and PHA-stimulated lymphocyte proliferation (Pockley et
al.,

1988).

Results

from

recent

research

indicate

that

the

immunosuppressive activity of PP14 may be mediated ty the suppression
of interleukin-1 (IL-1) secretion (Pockley and Bolton, 1990).
A second factor, known as pregnancy zone protein (PZP), is found
on the surface of the chorionic villi (Stimson, 1977; Chemnitz et al.,
1982).

PZP reportedly prolongs the survival of embryonal mouse heart

allografts (Svendsen et al., 1978) and suppresses T cell blastogenesis
in vitro, possibly ty reducing IL-2 production (Saito et al., 1990).
However, the significance of PP14 and PZP as immunosuppressors is
questionable considering they appear in maternal circulation during
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gestation (Julkunen et al.,

1985), and systemic immunosuppression

would be incompatible with healthy pregnancies.
Ungulate
Conceptus-derived immunosuppressive factors are not exclusively
characteristic of decidual type placentae.

Factors with similar

activities have been reported in several large domestic ungulate
species,
placentae.

sane

of

which

possess

epitheliochorial,

cotyledonary

Suppressor molecules have been obtained from uterine

secretions of pigs (Murray et al., 1978), sheep (Segerson et al.,
1984; Hansen et al., 1987) and cows (Segerson and Libby, 1990) as well
as fron supernatants of ovine and porcine conceptuses (Murray et al.,
1987).
cell

While all of the factors share the ability to suppress irrmune
function,

their

immunoregulatory mechanisms

and biochemical

compositions differ.
Suppression of lymphocytes by bovine (Roberts, 1977) and porcine
(Murray et al., 1978) uterine proteins was first reported many years
ago.

Murray et al. (1978) described the porcine suppressor proteins

as small, acidic proteins (approximately 15,000 d) that were present
in the uterus at day 15 of the estrous cycle.

Subsequent research by

other investigators focused more on pregnancy specific proteins and
led to the identification of ovine trophoblast protein-1 (Godkin et
al., 1984) and bovine trophoblast protein-1 (Godkin et al., 1988).
These factors belong to the alpha-interferon family (Imakawa et al.,
1987; Stewart et al., 1987), exhibit immunoregulatory activity and are
responsible for maternal recognition of pregnancy in their respective
species.

However, biochemically unrelated factors of a much higher
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molecular

weight

appear

to

be

largely

responsible

for

immunosuppressive activity in uterine/conceptus supernatants.
Segerson et al. (1984) purified two basic glycoproteins (UIM-P)
with molecular weights of 57,000 and 59,000 from uterine milk of
pregnant ewes (Days 125 and 130 of pregnancy).

UIM-P inhibited 3H-

thymidine uptake iy PHA-stimulated lymphocytes, was not cytotoxic and
did not lose its activity with routine handling and storage.

Further

characterization of uterine milk proteins was carried out using gel
filtration (Hansen et al., 1987).

The authors reported that the basic

protein fraction of uterine secretions contained the suppressive
substance and that the substance was large (eluted in the void volume
of Sephacryl S-200).

Furthermore,

the uterine

secretions were

obtained from non-gravid, ligated uterine horns of pregnant ewes, and
thus the factors were

identified as being of uterine,

and not

conceptus, origin.
In the same year, Murray et al.

(1987) reported purifying a

high-molecular-weight (MW >660,000) acidic glycoprotein (HMW3P) from
medium of cultured day 16 and 17 porcine and ovine conceptuses.
HMWGP

exhibited

a

tremendous

ability

to

inhibit

The

3H-thymidine

incorporation by PHA-stimulated lymphocytes, and this activity was not
a result of cytotoxicity.
While a number of studies have been carried out to identify and
characterize uterine- and conceptus-derived proteins, there is much
less information available concerning the suppressive mechanisms of
the numerous
pregnancies.

immunosuppressive

factors

associated

with

ungulate

Recently, information concerning suppressive mechanisms

has been obtained for ovine and bovine uterine luminal proteins (ULP)
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(Segerson, 1988; Segerson and Libby, 1990).

As these proteins were

obtained from uteri of pregnant

their

(conceptus or uterine)

animals,

is unknown.

specific

origin

Both ovine and bovine ULP

consisted of high (>248,000) and low (14,000-21,000) molecular weight
suppressor factors

(H-ULP and L-ULP,

respectively).

Ovine ULP

suppressed IL-2 mediated blastogenesis of T lymphocytes and the author
suggested that the suppressor mechanism was
alteration of the IL-2 system.

associated with

an

Bovine ULP involvement with IL-2 and

the IL-2 receptor of T lymphocytes was more extensively investigated
(Segerson and Libty, 1990).

Using 125I-IL-2 the authors determined

that L-ULP did not bind IL-2 tut H-ULP bound 70% of 125I-IL-2.
Furthermore, a very high-molecular-weight (1.76 x 10^ MW) component of
H-ULP bound 11.7% of 125I-IL-2 and inhibited binding of 125I-IL-2 to
the IL-2R of cow lymphocytes.
Rationale of Present Research
Based on evidence indicating that: 1) the trophoblast plays a
critical role in maintaining pregnancy,

2)

the maternal

immune

response is under local suppression at the fetal-maternal interface of
successful pregnancies and, 3) immunological rejection is responsible
for failed interspecies pregnancies,

we hypothesize that

factors

produced by the trophoblast are important in protecting the fetal
allograft and that, during interspecific pregnancy, such factors from
trophoblast of one species are frequently not capable of acting
effectively on maternal immune cells of another species.

To begin

testing this hypothesis, the effect of soluble suppressor factors had
to be characterized, first on allogeneic lymphocytes and subsequently

on xenogeneic lymphocytes, in order to identify any differences that
may be responsible for interspecific pregnancy failure.

In the first

experiment, the suppressive activity derived from sheep,

goat and

sheep x goat hybrid trophoblast was examined to determine if a
decreased suppressive capacity of hybrid tissue could he associated
with failure of hybrid pregnancies.

Subsequent studies were carried

out with horse conceptuses and trophoblast tissue.

The results of

this research indicate that, similar to that of other species studied,
horse

trophoblast

tissue

secretes

high-molecular-weight

soluble

factors capable of inhibiting maternal immune cell function.

A

>100,000 MW horse trophoblast tissue-derived suppressor factor was
identified.

The fact that this factor is produced fcy embryos as early

as day 9 and as late as day 26 of gestation, exhibits sane degree of
species-specificity and acts specifically on T lymphocytes, supports
our initial hypothesis.

The characterization of this suppressor

factor's effect on T cell expression of the IL-2R provides valuable
insight into the suppressive mechanism of this factor.

These results

increase

immunological

our

understanding

of

the

fetal-maternal

relationship in the horse and, because these findings are compatible
with those reported for other species, it seems likely that the events
responsible for fetal allograft protection are largely conserved
across species.

Therefore,

the results of these studies are a

significant contribution to the pool of information available to those
trying to determine the cause of interspecific pregnancy failure
and/or immune-mediated recurrent abortion. In addition, identification
of the suppressive mechanism associated with this suppressor factor
provides critical information that may be useful in future attempts to
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treat

recurrent

abortion

and

to

facilitate

the

survival

of

interspecific pregnancies ty altering maternal immune function in
utero.

CHAPTER IX
SUPPRESSION OF SHEEP AND GOAT LYMPHOCYTE
PROLIFERATION BY SHEEP, GOAT AND SHEEP X GOAT HYBRID
TROPHOBLAST TISSUE CULTURES 1
INTRODUCTION
The role of the mammalian placenta in protecting the fetal
allograft during pregnancy has not been clearly defined. Although
placental tissue expresses antigens early in development

(Pavia et

al., 1981; Allen et al., 1986; Billington and Burrows, 1986) and the
maternal immune system may generate anti-fetal antibodies (Allen et
al., 1987; MacLaren et al., 1990), intraspecies pregnancies proceed
uninterrupted.

It

has

been

suggested

that

conceptus-derived

immunosuppressor factors help protect the fetus from immunological
rejection (Mayumi et al., 1985; Clark et al., 1986; Daya and Clark,
1986; Murray et al., 1987; Crcy et al., 1988; Roth et al., 1990). The
protective mechanism normally involved during intraspecific gestation
seams to be ineffective in interspecific and hybrid pregnancies of
same closely related species (McGovern, 1975; Frels et al., 1980;
Clark et al., 1984). For example, the domestic sheep (Ovis aries) x
goat (Capra hircus) hybrid pregnancy is usually maintained for only 30
to 45 days and there is evidence for immunological involvement in the
loss of such pregnancies (Hancock et al.,1968; Dent et al.,1971;
McGovern,1973).
This study was designed to determine if medium conditioned with
trophoblast tissue of 20 day-old sheep x goat hybrid conceptuses

1 Roth, T.L., K.L. White and D.W. Hordhov. J. Anim. Sci. (In press).
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suppresses sheep and(or) goat lymphocyte proliferation, and to compare
hybrid suppressor activity to that of sheep and goat conceptuses.
MATERIALS AND METHODS
Animals.

Ovine conceptus donors were Suffolk ewes bred to

Merino rams. Does that served as both caprine and hybrid conceptus
donors were of various mixed breeds. A Nubian tuck and Barbados rams
were crossed with does to produce caprine and hybrid conceptuses,
respectively.
Superovulation and Breeding Regimen. Estrous cycles of 4
ewes and 8 does were synchronized by inserting intravaginal pessaries
containing 60 mg depo-provera (Upjohn, Kalamazoo, MI) for 10 days. To
superovulate

donors,

FSH

(Schering

Corp.,

Kenilworth,

NJ)

was

administered every 12 h for 3 days in decreasing doses of 4,4; 3,3 and
2,2 mg, respectively, starting 1 day prior to pessary removal. Donors
received an injection of .25 pg Cloprostenol (Estrumate, Bay Vet,
Shawnee, KS) coinciding with the second FSH injection.
Animals were observed for estrus twice daily starting on the
last day of FSH injections (day 0). Estrous ewes and 4 estrous does
were bred ty rams and bucks, respectively, every 12 h until no longer
in estrus. Similarly, the 4 hybrid donor does were allowed to breed
naturally with Barbados rams every 12 h until the end of estrus. To
ensure only pregnant donors underwent laparotomies, all mated donor
animals were observed for a return to estrus starting 16 days
following the last FSH injection. Animals were checked twice daily
until the day of conceptus collection (day 20).
Conceptus

Collection

and

Culture.

Conceptuses

were

collected at laparotomy from ewes and does 20 d following their last
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FSH injection (day 0). Only those animals that had been in estrus on
day 0 were used. Phosphate buffered saline (PBS) supplemented with 1%
calf serum (Hyclone, Logan, UT) and 1% antibiotic/antirrycotic was used
to flush pregnant uteri. PBS was injected into the uterine bod/ at the
base of each horn and conceptus tissue was collected via retrograde
flushing through a glass cannula (12 mm i.d.) inserted into the tip of
the uterine horn. Conceptuses were collected from nine animals, three
donors of each conceptus type (caprine, ovine and hybrid). Conceptuses
were

immediately rinsed threetimes in sterile

wereremoved from tissue.

Tissue

was

rinsed

PBS and all fetuses
once

in RHYH-1640

(Hyclone, Logan, UT) supplemented with 1% antibiotic/antirrycotic and
15% fetal calf serum (Hyclone, Logan, UT; non-heat-treated, <0.1 ng/ml
endotoxins) (RPMI+) and was divided into two or three approximately
equal sections. Each tissue section was placed in a tissue culture
flask (25 cm2)containing 15 ml RFME+. Conceptus tissue cultures were
incubated at 37°C in a humidified atmosphere of 5% CO2 and air for 24
h. To obtain trophoblast tissue-conditioned medium, the content of
each

culture was poured intoa 15 ml conical centrifuge tube and

centrifuged (600 x g; 30 min). Supernatant was filtered through a .22
Urn filter and was stored in 1 ml aliquots at -80°C. The tissue from
each culture was blotted dry and weighed. Average weights for sheep
(n=3), goat (n=3) and lybrid

(n=3) tissues were .34,

.33 and .34

gm/flask, respectively.
Lymphocyte Proliferation Assay.

Whole blood was collected

into heparinized tubes by jugular venipuncture from 4 randomly chosen
ewes and does. The blood was diluted with an equal volume of Hank's
basic salt solution (HBSS; Hyclone, Logan, UT) and 7 ml of the
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blood/HBSS mixture was layered over 4 ml Ficoll-Paque

(Pharmacia,

Piscataway, MJ). Following centrifugation in a 15 ml centrifuge tube
(550 x g; 30 min), the interface cells were collected and washed twice
with HBSS. The cell pellet was resuspended in R3FMI+ medium, cells were
counted on a hemacytometer and cell suspensions were diluted with
REMI+ to 4 x 106 cells/ml.
Lymphocyte cultures were carried out in triplicate in 96-well
round-bottomed tissue culture-treated plates

(Coming Glass Works,

Coming, NY). All wells received 1 x 105 cells (25 jll). Non-stimulated
and stimulated controls received 75 and 50 (Xl REMI+, respectively, and
stimulated controls also received 25 jll REMI+ containing .1 jig FWM.
Experimental wells were supplemented with 6, 3, 1.5 or .75 jll of
caprine,

ovine or hybrid conditioned medium

(CCM,

OCM and HCM,

respectively) diluted in 50 jll REMI+. For each type of conditioned
medium, samples of three cultures obtained from three different donors
were tested. All experimental wells also received 25 jll aliquots of
RHMI+ containing .1 jig PWM. Total volume in all wells was 100 jll. All
cultures

were

carried

out

simultaneously

using

suspensions and cultures were maintained at 37^

the

same

cell

in a humidified

atmosphere of 5% CQ2 and air. 3H-thymidine (1 jiCi/well; 6.7 Ci/mmol,
ICN, Irvine, CA) was added to cultures 96 h after the start of
incubation, and cells were harvested at 112 h with a Skatron automatic
cell harvester (Flow Laboratories, Rockville, MD). Radioactivity, a
measure of cell proliferation, was determined by liquid scintillation
counting. Prior to harvest, percent cell viability was determined in
wells of each treatment group by trypan blue exclusion.
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Statistical Analysis.

Data reported as percent of stimulated

control was calculated for triplicate wells using the equation (%
control = average cpn of experimental cultures / average cpm of
stimulated control cultures X 100). Results were analyzed in a 3 x 4
factorial ANOVA. (3 conceptus types and 4 volumes of conditioned
medium) using the general linear model procedures of the statistical
analysis systems (SAS) computer package (Luginbuhl et al.,

1985).

Randan

Highly

variables

were

lynphocytes

and

conceptuses.

insignificant (P>.75) interactions were deleted from the model and
appropriate error terms were used to test the main effects, i.e.
variation attributed to species of lymphocyte was tested with the
error term lymphocyte within species and variation due to type of
conceptus was

tested using conceptus within

type.

Tukey's

mean

comparison tests were used to compare the effects of different volumes
of conditioned medium and to determine differences between sheep and
goat lymphocyte suppression within CCM, HCM and OCM treatment groups.
RESULTS
The superovulation and breeding regimen proved effective in
that, with the exception of one goat conceptus donor,

all donor

animals exhibited numerous corpora lutea and multiple conceptuses were
obtained

from

conceptuses,

each

animal. When

compared

to

goat

hybrid conceptus tissue appeared healthy

and

sheep

and

fetal

development normal, indicating that failure of hybrid pregnancy had
not yet occurred.
Medium conditioned with ovine, caprine and hybrid trophoblast
tissue

suppressed

(Pc.01)

both

sheep

and

goat

FWM-stimulated

lymphocyte proliferation in a dose-dependent manner (Figures 1 and 2).

Conditioned Medium Added (jil/well)
Figure 1.
The effect of caprine, ovine and hybrid
trophoblast tissue-conditioned medium (CCM, OCM and HCM,
respectively)
on
PWM-stimulated
sheep
lymphocyte
proliferation. Values representmean percent of stimulated
control i SEM (n=12). Overall suppressor activity did not
differ (P>.05) between treatments.
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2.
The effect of caprine, ovine and hybrid
trophoblast tissue-conditioned medium (CCM, OCM and HCM,
respectively)
on
PWM-stimulated
goat
lymphocyte
proliferation. Values represent mean percent of stimulated
control — SEM (n=12). Overall suppressor activity did not
differ (P>.05) between treatments.
Figure
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The overall suppressor activity of CCM, OCM and HCM on lymphocytes of
either sheep or goats did not differ (P>.05). Data corrparing sheep and
goat lymphocyte proliferation within each type of conditioned medium
are in Table 1. The results indicate that proliferation of sheep
lynphocytes was suppressed more than that of goat lymphocytes when
treated with CCM, OCM or HCM (Pc.Ol, Pc.Ol and P<.05, respectively).
Viability of lynphocytes at the end of culture was consistently 85-95%
across all treatments.
DISCUSSION
Evidence supporting the theory that the placenta plays an
important role in maintaining the fetus as an allograft in the mother
has been obtained through the use of embryo manipulation techniques.
The injection of embryonic cells from one species into blastocysts of
a different species can result in successful interspecies pregnancies
provided the placenta and recipient are of the same species (Rossant
et al., 1982; Fehilly et al., 1984; Meinecke-Tillman and Meinecke,
1984; Polzin et al., 1987). This technique has been used to produce
healthy offspring containing sheep x goat hybrid cells (Roth et al.,
1989). These results indicate that the hybrid placental tissue, not
the fetal cells, is responsible for the failure of sheep x goat hybrid
pregnancies. One explanation for this failure may be a deficiency in
the ability of hybrid trophoblast tissue to create and maintain an
immunosuppressive environment at the fetal-maternal interface.
While

there

have

been

a

number

of

reports

concerning

immunosuppressive activity in ovine uterine fluid during intraspecies
pregnancies (Hansen et al., 1987; Segerson et al., 1984; Segerson,
1988),

there has been less published data pertaining

to

ovine
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TABLE 1.
Suppression of PWM-stimulated sheep and
goat lymphocyte proliferation by caprine, hybrid and
ovine
trophoblast
tissue-conditioned
medium (CCM,
HCM and OCM, respectively)a.
Conditioned medium^
______ Jarvr* ,

Medium
(fil/w ell)
.75
1.5
3
6

Goatd
51.6
37.3
23.8
1 2. 0

±
±
±
±

2.6
1.9
2.4
1.1

Goatd

68.8 ± 1 .5
54. 7 ± 2 . 3

37. 3 ± 3 .2
21 . 2 ± 1. 7

38 . 5 ± 2 . 5
23.3 ± 2.0

10. 3 ± 1. 8
5 . 3 ± 1. 0

49. 2
35 . 6
26.1
14. 1

±
±
±
±

1. 2
1. 8
3. 1
2.0

39. 1 i 4. 3
25 . 8 ± 2 . 7
15. 5 ± 2 . 7
9 .0 ± 1. 7

53. 7
41.8
32. 8
22.3

±
±
±
±

3. 3
2. 8
3. 1
2.4

aValues represent (mean ± SEM) percent of sheep (n=4) and
goat (n=4) stimulated controls (109,000 and 183,000 cpm,
respectively). Non-stimulated control (background) values
for sheep and goat were 5,330 and 6,100 cpm, respectively.
^Medium conditioned by the 24 h culture of 20 d-old caprine,
hybrid and ovine trophoblast tissue (CCM, HCM and OCM,
respectively).
cTukey's mean comparison test was used to determine
differences
in overall
sheep
and
goat
lymphocyte
proliferation within the conditioned medium.
Suppression of goat lymphocyte proliferation
(P<.01) than that of sheep lymphocytes.

was

less

Suppression of goat lymphocyte proliferation
(P<.05) than that of sheep lymphocytes.

was

less
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conceptus-derived suppression (Murray et al., 1987; Staples et al.,
1983) and information is lacking regarding that of the sheep x goat
hybrid conceptus. In this study, we focused on the production of
irmtunosuppressor factors hy the developing placenta. The cultures
contained conceptus trophoblast tissue devoid of the amnion, which was
discarded with the fetus. Therefore, the immunosuppressive activity of
CCM, OCM and HCM, reported herein, was derived specifically from early
placental tissue of 20 day-old goat, sheep and sheep x goat hybrid
conceptuses, respectively.
Conceptuses were collected on day 20 of gestation for two
primary reasons. First, because hybrid pregnancy loss occurs between
days 35 and 45 of gestation (Hancock et al., 1968; Tucker et al.,
1971; McGovern, 1973) and has been reported as early as day 30
(Hancock et al., 1968), we wanted to ensure that healthy conceptus
tissue was obtained. Our collection of numerous, apparently normal
hybrid conceptuses was not unexpected as others have reported normal
hybrid fetal and placental development until day 30 to 35 of pregnancy
(Hancock and Jacobs,

1966;

Hancock et al.,

1968),

beyond which

excessive lymphocyte infiltration (Hancock et al., 1968) and increased
allantoic fluid accumulation occurs

(McGovern,

1977).

The second

reason for collecting day 20 conceptuses was based on the hypothesis
that these reported abnormal characteristics result from a disruption
of the immunoregulated uterine environment. Such a disruption would
likely

occur

some

time

prior

to

the

manifestation

of

these

abnormalities. Therefore, if conceptus-derived suppressor factors are
involved with controlling uterine immune function, there may be some
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change in the immunosuppressive competence of the hybrid conceptus as
early as day 20 of gestation.
The

results

of

this

study

indicate

that

HCM

effectively

suppressed in vitro sheep and goat lymphocyte proliferation and,
therefore, the findings fail to support the hypothesis that a lack of
conceptus-derived immunosuppressive activity precedes rejection of the
hybrid conceptus. However, a decrease in immunosuppressive activity
may occur closer to the time of fetal death and simply cannot be
detected on day 20 of gestation. Alternatively, the production and (or)
functions of conceptus-derived suppressor factors may be altered while
in vivo via fetal-maternal tissue interactions, tut once removed from
the uterine environment and placed in culture, the production and (or)
functions of these factors resume. Finally,

it is possible that

suppressor factors are consistently produced during early hybrid
gestation, but other events lead to maternal lynphocyte escape from
suppression and, perhaps, to their attack of the hybrid conceptus.
Maternal lynphocyte evasion of suppression may be mediated via
strong antigenic stimulation. Xenogeneic antigens expressed on hybrid
and interspecific placental tissue may have more stimulatory impact on
the maternal immune system than allogeneic fetal antigens, thereby
disrupting the seemingly compatible fetal-maternal relationship that
normally exists during intraspecific pregnancy. Although much is still
unknown about this intimate relationship between maternal and fetal
tissue, in the two most intensively studied models of interspecies and
hybrid pregnancy (murine and equine) the immune response seams to play
an integral role in implantation and placentation. Murine embryo
inplantation is associated with lynphocyte accumulation at the fetal-

49

maternal interface (Slapsys and Clark, 1982; Slapsys and Clark, 1983)
tut only in unsuccessful interspecies or hybrid pregnancies does the
trophoblast become infiltrated with lynphocytes (Cray et al., 1982).
m intraspecific equine pregnancies, lynphocytes accumulate around the
endometrial cups tut do not penetrate into the cup tissue until days
70 to 80 of gestation

(Allen, 1982). However,

in equine hybrid

pregnancies, lynphocyte invasion of the cups occurs much more rapidly
with complete loss of endometrial cips occurring at day 60 (Allen,
1969; Allen, 1982). Similarly, the excessive lynphocyte infiltration
observed in sheep x goat hybrid pregnancies (Hancock et al., 1968) is
in contrast to a noted decrease in accumulated uterine lynphocytes
following

attachment

of

the

conceptus

in

intraspecific

ovine

pregnancies (King et al., 1982). Together, these data may indicate a
local suppression of the maternal immune cells at the fetal-maternal
interface is ineffective in hybrid and interspecific pregnancies
probably due to a disruption of suppressor activity and (or)

an

overriding irrmune response against xenogeneic antigens. At day 20 of
pregnancy, the ovine and caprine conceptus has attached (Leiser, 1975;
King et al., 1982) but interdigitation of chorionic microvilli in
developing placentomes does not occur until

the fourth week of

gestation (Boshier, 1969; Dent, 1973). As this event is likely to
provide the antigenic stimulation that may initiate changes leading to
maternal

immunological

rejection,

it

is

possible

we

obtained

conceptuses prior to any immunological alterations in the uterine
environment
activity.

that

could

affect

subsequent

placental

suppressor
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HCM suppressed sheep and goat lynphocytes as effectively as OCM
and CCM. However, it is important to point out that FWM was used to
stimulate lynphocyte proliferation and, in a previous study involving
horse conceptus-derived suppression, Roth et al. (unpublished data)
found that PSMI-stimulated lynphocytes were easier to suppress than
phytohemagglutinin-

or

lipopolysaccharide-stixnulated

lynphocytes.

These results indicate that the type of antigen stimulating the
lynphocytes plays

a

role

in

determining

the

extent

to

which

proliferation is suppressed by conceptus suppressor factors. In utero,
lynphocytes stimulated by hybrid placental xenoantigens may be more
difficult to suppress than those stimulated with intraspecific fetal
alloantigens. Therefore, the apparent equality of suppressive activity
of HCM, OCM and CCM in in vitro FWM-stimulated lynphocyte assays may
not be an accurate assessment of the in vivo situation. Unfortunately,
an in vivo analysis of lynphocyte-conceptus tissue interaction was
beyond the scope of this study.
The reported difference between sheep

and

goat lynphocyte

suppression within each treatment (Table 1) is likely a reflection of
the

difference in species responsiveness to

the PWM. To ensure

consistency across all assays, the same PWM concentration (.1 ^ig/well)
was supplemented to all stimulated cultures. This concentration is one
that provokes a strong proliferative response in lynphocytes of both
species. However, when a mitogen titer assay was carried out for goat
and sheep lynphocytes, the optimal lynphocyte responses were achieved
using .1
PWM

and .2 jog/well, respectively (unpublished data). Thus, the

dose used in the assay was

slightly

suboptimal for

sheep

lynphocytes, which may explain the lower stimulated control values and
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the greater suppression of sheep lynphocytes with CCM, OCM and HCM
when compared to that of goats.
In summary, superovulation of does followed by natural mating
with Barbados rams may result in numerous hybrid conceptuses with
apparently normal fetal development and healthy trophoblast tissue at
day 20 of gestation. Medium conditioned with hybrid trophoblast tissue
will

suppress

proliferation

of

EWM-stimulated

sheep

and

goat

lynphocytes. No differences between suppressive activity of CCM and
OCM or HCM obtained from 20 day-old conceptuses was determined. These
results indicate that, at day 20 of gestation, sheep x goat hybrid
trophoblast does not differ from ovine or caprine trophoblast in its
ability to suppress PlM-stirnulated lynphocytes.
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INTRODUCTION
The mechanism by which the fetal allograft escapes maternal
immunological attack during pregnancy remains largely unknown. It is
well documented that fetal tissue in intimate contact with uterine
epithelium expresses

antigens

early

in

development

(Chatterjee-

Hasrouni and Lala, 1981; Pavia et al., 1981; Allen et al., 1986). The
maternal immune system recognizes the fetal antigens and frequently
responds with a humoral immune response. Antibodies against fetal
antigens are present in the maternal circulation of up to 90% of
pregnant mares (Allen et al., 1987). A cell-mediated immune response
also seems to occur at the fetal-maternal interface, and may even be
essential

for proper implantation

(Beer et

al.,

1975).

These

immunological events have no detrimental effects on the fetus or
placenta

of

natural

intraspecific

pregnancies.

Yet

with

many

interspecific or hybrid pregnancies, the protective mechanism normally
involved during gestation seems to be

ineffective,

and abortion

generally occurs (McGovern, 1975; Clark et al., 1984). The production
of chimeric embryos, resulting in a placenta derived mainly from an
embryo of the recipient maternal species and the fetus originating
from a different species or hybrid embryo, makes it possible to
produce offspring from recipients that will not otherwise carry the
2 Roth, T.L., K.L. Mute, D.L. Thorpson, Jr., B.E. Barry, J.S. Capehart, D.R. Colbom
and M.H. Rabb. 1990. Biol. Reprod. 43:298-304.
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fetus to term (Rossant et al., 1982; Fehilly et al., 1984; Polzin et
al., 1987; Roth et al., 1989). During such chimeric pregnancies,
antibody titers against xenogeneic and allogeneic antigens have been
identified in maternal circulation, yet the fetus remains unharmed and
is successfully carried to term (Ruffing et al., 1988; McLaren et al.,
1990). Hence, it seems possible that the placenta plays a role in
blocking maternal immunological attack (tut not recognition) of the
fetus, and that the placenta must he of the maternal species in order
to efficiently perform this protective mechanism.
Interest in the potential role of the conceptus in regulating
maternal immune function has led to the identification of conceptusderived products with immunoregulatory functions in several domestic
species (Clark et al., 1986; Murray et al., 1987; Cray et al., 1988;
Pandian et

al.,

1988).

Seme products have been

identified

as

interferons (Cross and Roberts, 1989) and are responsible for maternal
recognition of pregnancy (Roberts et al., 1985). Others have been
identified as immunosuppressive factors when tested in vitro, but
their exact mechanism of action or significance in vivo has yet to be
elucidated.
protecting

If these suppressor factors play a critical role in
the

conceptus

from immunological

attack,

then

their

inability to act effectively across species' lines may provide an
explanation for early loss of interspecific pregnancies. In this study
we have identified an immunosuppressive substance produced by the pre
implantation

horse

characteristics.

conceptus

Furthermore,

and
we

have
have

determined
examined

sane

the

activity of this substance on lynphocytes of other species.

of

its

suppressive
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MATERIALS AMD METHODS
Animals

and

Embryo

Collections.

Fifty-five mares

of

various lighthorse breeds were teased daily by stallions to identify
those in estrus. Estrous mares were artificially inseminated with
fresh, raw semen (5 x 106 progressively motile sperm) on the second
day

of

estrus

and

every other day

thereafter until

ovulation

(determined by daily palpation and/or ultrasonography). Conceptuses
were collected at three stages of gestation: Group I - day 9-10, Group
II - day 15-16 and Group III - day 25-26 (ovulation = day 0). A total
of six Group I conceptuses were collected from six different mares by
the non-surgical embryo collection procedure previously described by
Imel et al. (1981). Ultrasonography was used on day 12 to determine
pregnancy in Group II and III conceptus donor mares. Three Group II
and III conceptuses from six different mares were recovered ty a
modified non-surgical uterine flushing technique. Mares were lightly
sedated with 1-3 ml Rompun (Mobay, Shawnee, KS) administered iv five
minutes prior to initiating the flushing procedure. The mare's cervix
was mechanically dilated ty digital palpation. Sterile tygon tubing
(18 mm i.d.) was inserted into the vagina and manipulated through the
dilated cervix into the uterine body. Throughout the procedure the
cervix was held firmly around the tubing to maintain the tubing's
position and to prevent fluid leakage from the uterine body out of the
relaxed

cervix.

Sterile

PBS

supplemented

with

1%

antibiotic/antimycotic and 1% calf serum was poured into the external
end of the tubing. Gauze was placed over the exposed end of tubing and
air was blown in, forcing the fluid into the uterus. This process was
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repeated until no more fluid would enter the uterus. The gauze was
removed and the uterine effluent was collected into a sterile flask.
Conceptus

Cultures.

All conceptuses were rinsed under

sterile conditions five times with RPMI+ and were placed in tissue
culture flasks containing RR4I+

as follows: Group I - two embryos/4

ml, Group II - one conceptus/12

ml and Group III - one conceptus/30

ml. All cultures were incubated at 37°C in a humidified atmosphere
containing 5% C02 and air. RFMI+ cultured alone served as control
medium (CM). Cultures were terminated at 24 ± 1 h. Horse conceptus
conditioned medium (HCCM) was obtained from cultures, centrifuged at
1500 x g for 20 min and filtered through a .2 pm filter.
Lymphocyte proliferation assay.

Heparinized whole blood,

obtained by jugular venipuncture from 3 randomly chosen mares served
as a source of peripheral blood lymphocytes (PELs).

Blood from each

animal was separately mixed with an equal volume of HBSS. Ten ml of
the blood-HBSS mixture were layered over 4 ml Ficoll-Paque in a 15 ml
conical tube and samples were centrifuged for 20 min at 500 x g.
Interface cells from each horse were pipetted into separate centrifuge
tubes and rinsed twice with 8

ml HBSS

(400 x g;

10 min).

The

peripheral blood mononuclear cells were resuspended in RPMI+, counted
on a hemacytometer and diluted to a final concentration of 4 x 106
cells/ml.

Cultures were carried out in triplicate in 96-well round-

bottom tissue culture treated plates. All wells received 1 x 10^ cells
(25 |Xl). Stimulated cultures received 25 jll aliquots

of

RPMI+

containing one of three mitogens: 1 jig PHA, 1 jig PWM or 5 jig Con A.
HCCM from Groups I and II was tested on T cell mitogen (PHA and Con A)
stimulated lymphocytes to ensure that the observed suppression was not
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EV2M or B cell specific. In addition to mitogen, experimental wells
received 0, 25 and 50 Jll HCCM while control wells received similar
quantities of CM. Mon-stimulated cultures contained cells in REMI+
only. All wells contained a final volume of 100 Jll. Each of the three
HCCM samples in each of groups I-III was tested on PBLs from 3-4
randomly chosen mares. Cultures were maintained in an incubator at
37°C in a humidified atmosphere with 5% C02 and air. ^H-thymidine was
added to cultures (1 Jici/well) at 96 i 2 h and cells were harvested 16
1 2 h later onto glass fiber filters using a Skatron automatic cell
harvester. Radioactivity on the filters was determined by liquid
scintillation counting. Prior to harvest, percent cell viability in
control and experimental cultures was determined by trypan blue
exclusion.
HCCM Characterization.

Characterization tests were carried

out with a pool of HCCM derived from three 20-day conceptuses
collected and cultured for 48 h as described above, each in 20 ml
RFMI+. After centrifugation and filtration, the sample was stored at 80°C in 1.5 ml aliquots.

RIMI+ alone was

cultured

and

stored

identically to serve as CM for all treatments. To further decrease
intra- and inter- assay variability and to increase assay sensitivity,
mitogen titer assays were run on lynphocyte donors to determine the
optimal mitogen dose for each donor. PWM was serially diluted from 4
to .05

fig/well and three mares responding optimally to the same

mitogen dose of.2 jig/well served as PBL donors for all subsequent
assays with EVM as the stimulating mitogen. For heat-treatment (HT),
aliquots of HCCM and CM were thawed to room temperature, and a 600-jxl
sample of each was placed in a sterile glass vial and held in a beaker
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of water at 90°C for 30 min. Freeze-thaw treatment (FT) consisted of
placing 600 fi.1 HCCM and CM each in a 1 ml cryovial and freezing to 80°C, followed by thawing to room temperature for a total of eight
cycles. Two other 600-fil samples of HCCM and CM were filtered two
times each through a .2 }im nitrocellulose filter (NCF). A final 600-|il
untreated fresh-frozen (FF) sanple of each HCCM and CM was conpared to
treated samples. Serial dilutions of all HCCM and CM samples were made
with RFMI+ and samples were added to lynphocyte cultures at .75, 1.56,
3.23, 6.25, 12.5 and 25 p.l/well (total well volume = 100 (Xl). To
identify the approximate size of the substance causing suppression,
500 (ll samples were centrifuged at 4500 RTM for 30 min. through amicon
microconcentrators (Amicon, Danvers, MA) with MW exclusions of 10,000
and 30,000. Sanple concentrates were rinsed ty diluting with 500 (J.1
REMI-1640 and spinning again at 4500 RTM for 30 min. Concentrate was
again diluted back to its original 500 |ll volume with REMI-1640. The
two MW fractions of HCCM and CM were added to lynphocyte proliferation
assays in quantities of 2, 4 and 8 (ll sanple/well to test for
suppressive activity.
Interspecies Assay.

The suppressive effect of HCCM on goat,

donkey and horse lynphocytes was

conpared.

FWM-titer

assays as

described for horse PBL donors were used to screen potential goat and
donkey PBL donors. Three does and three jennies with optimal responses
at

.2 pg/well FWM were chosen for the interspecies assay.

EVJM-

stimulated lynphocyte proliferation assays were set up as described
previously with lynphocytes from the three chosen PBL donors of each
species and with HCCM or CM added at .4, .8, 1.6 , 3.2 , 6.4 and 12.8
^ll/well (total well volume = 100 (J.1).
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Statistical

Analysis.

Average cpm and % of stimulated

control for triplicate or quadruplicate wells were determined. Results
(cpm) from the addition of HCCM of Group I, II and III cultures to
lynphocyte proliferation assays were analyzed ty ANOVA using the
general linear model procedures of the SAS computer package (Luginbuhl
et al., 1985) to determine suppressive activity of HCCM.

Linear and

quadratic contrasts were used to determine the relationship between
the addition of 0, 25 and 50% HCCM and percent suppression. HCCM
induced suppression was conpared between groups by Tukey's mean
conparison tests.

Results from treated HCCM and interspecies assays

were expressed as average cpm and/or percent of stimulated control and
were similarly analyzed ty ANOVA and Tukey's mean comparison tests.
Polynomial

regression analysis was used

to

conpare

suppressive

activity curves in the interspecies assay.
RESULTS
Groups I-1II.

When supplemented to cultures at 25% or 50% of

the total well volume, HCCM from Groups I, II and III suppressed
lynphocyte proliferation (Pc.001) induced ty PWM, while CM exhibited
no suppressive activity

(P>.05) when similarly added to cultures

(Table 2). In all groups, there was a linear relationship (P<.01)
between % suppression and the addition of 0, 25 and 50% HCCM. HCCM
also suppressed lynphocyte stimulation (P<.001) induced ty Con A and
PHA when added to cultures at 25% and 50% of well volume. Viability of
cells in experimental wells was always 85-95% at the end of the
culture period.
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TABLE 2. Effect of control medium and HCCM
Groups
I-III
on
mitogen-stimulated
horse
proliferation.a

from
PBL

Mitogen —St xmulat ion
Source of
Medium l&Yfill -Jaonfi_
Group I 0
(Day 9-10) 0
25
50

6,896 ± 2,299

Group II 0
(Day 15-16) 0
25
50

35,286 ± 5,377

Group III 0
(Day 25-26) 0
25
50

14,018 ±2,194

Control
Medium

0
0
25
50

PWM*>
37,504 ± 6,240
21,745 ± 3,986*
19,312 ± 3,668*

ConAc

PHa£39,260 ± 4,423
19,882 ± 3,198*
17,816 ± 2,843*

85,480 ± 5,724 53,783 ± 4,431
22,547 ± 5,067* 23,647 ± 3,971*
9,766 ± 2,428* 11,349 ± 2,262*
61,899 ± 5,384
33,193 ± 6,179*
19,975 ± 4,706*
6,896 ±2,299
37,504 ± 6,240
43,462 ±6,230
43,197 ±5,823

aGroup I and control medium data represent mean cpm ± SEM
for three day 9-10 HCCM samples and three CM samples,
respectively, each tested on three PBL populations (total
n=9) . Group II and III values are the mean cpm ± SEM from
three day 15-16 HCCM samples and three day 25-26 HCCM
samples, respectively, each tested on four PBL populations
(n=12). HCCM from all Groups (I,II and III) added at 25%
and 50% of well volume suppressed lymphocyte prolferation
(P<.001) in mitogen-stimulated cultures, but CM did not
(P>. 05) .
Supplemented to cultures at 1 ^ig/well.
Supplemented to cultures at 5 |lg/well.
*Significant lymphocyte suppression relative to stimulated
controls (Pc.001).
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HCCM Characterization.

After treatment (HP, FT, NCF), the

addition of increasing volumes of HCCM suppressed (P<.05) PWM-induced
lymphocyte proliferation

in a

dose-dependent

manner

(Table

3).

Similarly treated CM did not suppress (P>.05) proliferation (data not
shown). There was no difference in overall

suppressive activity

(determined as % of stimulated control) of HCCM between treatments,
nor did suppressive activity of treated samples differ (P>.05) from
that of non-treated (FF) HCCM (Fig. 3).
The

fractions of HCCM separated by

exclusion amicon microconcentrators

10,000

suppressed

and

30,000 MW

(Pc.Ol)

lymphocyte

proliferation with the larger MW HCCM fraction significantly more
suppressive (P<.01) than the smaller MW fraction (Figs. 4 and 5). The
addition of 8 Jil/well of HCCM filtrate and retentate fractions
decreased the percent stimulation to 71.3 -± 5.0 (mean i SEM) and 21.4
±1.7 respectively (10,000 MW exclusion centricon), and 77.2 ■£ 5.1 and
28.4 ± 9.1 respectively (30,000 MW exclusion centricon), while the
addition of either MWfractions of CM had no

suppressive effect on

percent lymphocyte proliferation (103.6 ± 5.1 and 118

7.1 (10,000 MW

centricon) and 112.3 ± 1.0 and 108.5 ± 7.3 (30,000 MW centricon)).
Interspecies Assay.
horse

FWM-stimulated

proliferation across
(determined relative

The addition of HCCM to goat, donkey and

lymphocytes decreased
all
to

species (Fig.

(P<.05)

6).Overall

stimulated controls)

was

lymphocyte
suppression

less

in

goat

lymphocyte cultures than that in horse or donkey cultures (P<.05), but
there was no difference between percent suppression of donkey and
horse cultures. Polynomial regression analysis used to describe the
dose response suppression curves resulting from the addition of HCCM
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TABLE
horse

3.
PBL

Effect of treated HCCM on
proliferation.3

PWM-stimulated

JRgfiM Treatment
HCCM added
lUl/welJ.)

0.0

0.75
1.56
3.125
6.25
12.5
25.0

FreshFrozen

70,483 ± 3,844
36,370 ± 473
20,959 ± 1,504
15,075 ± 1,076
8,986 ± 881
5,107 ± 457
3,056 ± 248

Frozen-

Heat-

Thawed

Treated

Nitrocellulose
Filtered

73,645 ± 5,156
30,281 ± 684
21,098 ± 1,587
13,400 ± 1,286
11,707 ± 1,007
5,178 ± 556
3,184 ± 283

77,985 ± 4,719
33,363 ± 1,439
21,790 ± 1,910
9,627 ± 1,817
5,382 ± 1,641
2,904 ± 362
1,527 ± 122

39,048 ± 9,774
21,662 ± 5,735
14,645 — 4,427
8,078 ± 2,787
4,424 ± 1,914
2,463 ± 1,097
1,434 ± 580

12,843 ± 3,122

13,998 ± 3,402

2,951 ± 1,316

Non- stimulated
14,579 — 2,208

aData represent mean cpm i SEM (n=3). All samples expressed
suppressive activity (P<.05) relative to stimulated controls
(0.0 ^ll/well) .
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Figure 3 . Suppressive activity of treated (heat-treated 90^ for 30
min (HT), filtered 2x through a .2 Jim nitrocellulose filter (NCF),
frozen to 80°C and thawed to roan temperature 8x (FT)) vs non-treated
fresh-frozen (FF) HCCM on FWM-stimulated PBL proliferation. Columns
represent mean % of control + SEM (n=3) with the addition of
increasing quantities of HCCM.
All saitples expressed suppressive
activity (P<.05), and there was no difference (P>.05) between the
activity of treated and non-treated HCCM.
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by amicon microconcentrator centrifugation.
Values
represent mean % of stimulated control i SEM (n=3) . Both
HCCM fractions were suppressive compared to CM fractions
(P<.05).
Different superscripts denote significantly
different suppressive activity (P<.05).
Figure 4.
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Figure 5. Effect of >30,000 MW and <30,000 MW fractions of
HCCM and CM on PWM-stimulated PBL. Fractions were separated
by amicon microconcentrator centrifugation.
Values
represent mean % of stimulated control — SEM (n=3) . Both
HCCM fractions were significantly suppressive (P<.05)
compared to CM fractions.
Different superscripts denote
significantly different suppressive activity (P<.05).
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Equations:

Control

Goat y = 79.8 - 5.9x
Donkey y = 75.1 - 12x + .56x2
Horse y - 68.8 - 15.7x + .72x2

of Stimulated

Donkeyb
Goatc
Horse b
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Effect of HCCM on FVM-stirnulated PBL of horses, donkeys
and goats. Values are mean % of stimulated control ± SEM (n=3) of PEL
with the addition of increasing quantities of HCCM.
Overall
suppression of goat PBL was less (P<.05) than that of horse or donkey
PBL.
There was no difference (P>.05) between horse and donkey PBL
suppression. The goat suppressor curve follows a linear regression
equation while the donkey and horse curves follow quadratic equations
with the same slope (ANOR; r2=.88).
Figure 6.

a% stimulated control = average cpm experimental/average cpm
stimulated control x 100.
Average cpm for goat, donkey and horse
stimulated controls were 122,542, 78,199 and 46,036 respectively.
b 'different superscripts denote significant differences in overall
suppression caused by HCCM supplementation (P<.05).
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to lymphocyte cultures of the three species determined that the curves
representing horse and donkey lymphocyte suppression had the same
slope and were best fit by a quadratic equation while the goat's best
fit a linear equation.
DISCUSSION
The data presented herein indicate that the preirrplantation
horse conceptus produces a factor that suppresses in vitro mitogeninduced horse lyirphocyte proliferation.
mediated

through

cytotoxicity.

The

This

suppression

substance

is not

responsible

for

suppressive activity is released by the embryo as early as day 9-10 of
development and continues to be produced at least through day 26 of
gestation. All horse embryos collected at day 9-10 had hatched from
their zonae pellucidae and were surrounded by the equine embryonic
capsule. Whether or not these embryos produce a suppressor substance
prior to hatching from their zonae was not determined. It is possible
that the embryo, while surrounded by the fairly non-antigenic zona, is
not in danger of immunological attack and thus may not produce a
suppressor factor. It has been reported that bovine conceptus-derived
suppressor activity is non-detectable prior to day 10, variable from
day 10-12 and only definitely present by day 14

(Cray et al., 1988).

Such reports indicate that, at least in cattle, suppressor substances
are not produced and/or release! by the embryo prior to zona hatching.
It is possible however, that suppressor factors are produced early but
in such small levels that they are not detected by the in vitro
biological assay used to evaluate suppression. Suppressive activity of
HCCM varied between, but was definitely present in, the three day 9-10
cultures. The HCCM with the greatest suppressive activity was that
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from cultures in which embryos remained fully expanded and grew in
size during the 24 h culture period. This observation may .indicate
that the production of the suppressor factor correlates either with
the health of the embryo or simply with an increased number of cells
capable of producing the substance. It has been proposed that the
measure of embryo-derived irrmunoregulatory function could be used in
predicting the viability of embryos prior to their transfer to
recipients. However, in the cow such an assay would not be practical
since suppressor activity of embryos is not detected until after day
10, and embryo transfer in cattle is carried out between days 6 and 8.
The transfer of embryos at day 9 in the horse is successful, and since
equine embryos seem to express immunosuppressive activity at this
stage of development, it is possible that a measurement of this
function could be useful in predicting post transfer embryo survival.
To do so, a quicker more sensitive assay than lymphocyte proliferation
would be required. The difference in suppressive activity of HCCM from
Group I vs. Group II and III is likely simply due to the difference in
the tissue:medium ratio in the cultures,

resulting

in

a

lower

concentration of the day 9-10 embryo-derived factors.
Because production of the suppressor factor begins as early as
day 9 and continues through day 26, it is not likely that this
substance is responsible for maternal recognition of pregnancy, which
occurs between day 13 and 15

(Hershman and Douglas, 1979). Such

proteins in other species are produced mainly during the specific
window when maternal recognition occurs (Davis and OTT, 1989; Godkin
et al., 1989). However, we can not rule out the possibility that the
substance plays a role in the event.
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Lymphocyte proliferation induced by any of the three different
mitogens was suppressed by the addition ofHCCM indicating that

the

suppressor factor is non-antigen specific. Furthermore, the use of Con
A and PHA (T-lynphocyte stimulators) and FWM (a T and B-lymphocyte
stimulator)

indicates

the

suppressor

factor

might

affect

both

lymphocyte subsets. However, because FWM is a T-cell dependent B-cell
stimulator, it is possible that FWM B-cell stimulation is suppressed
indirectly ty suppression of T-cells which results in decreased
lyrtphokine production

(Sharon,

1983; Weiss,

1989). The fact that

lymphocyte proliferation was not affected ty the addition of CM to the
lymphocyte cultures ensures the suppression observed with HCCM is not
an artifact resulting from the use of certain flasks or incubation
regimens. Lymphocyte suppression resulting from the incubation of
medium in certain flasks or plates has been reported previously (Crcy
et al., 1988).
The immunosuppressive effect of progesterone and other steroid
hormones is well documented, tut the level of hormone required to
suppress lymphocyte proliferation

in vitro

exceeds physiological

levels. As much as 5 |xg/ml is required in order to achieve suppression
of PHA and Con A stimulated lymphocyte proliferation (Mori et al.,
1977;

Siiteri

and

Stites,

1982).

Only

picogram

to

nanogram

concentrations of hormones are found in equine blastocoelic fluid or
in equine conceptus culture medium (Flood et al., 1979; Marsan et al.,
1987)

indicating that,

hormone

even localized around the conceptus,

levels produced would be

far below that

suppressing lymphocyte proliferation. However,

required

the
for

to ensure that the

suppression we observed was not hormone-induced, HCCM was run through
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the amicon microconcentrators with MW exclusions of 10,000 and 30,000.
Since the suppressor substance was found to be >30,000 MW we can
conclude that it is not a steroid hormone. The fact that the <30,000
and <10,000

fractions were slightly suppressive might indicate the

presence of hormones and/or interferons in those smaller MW fractions.
HCCM was subjected to harsh treatments of freeze-thawing and
heating at 90°C for 30 min in an attempt to denature the proteins in
the sample. Because no loss of biological activity of the HCCM
suppressor factor was observed after treatments, it is possible the
substance is not a protein. Alternatively, it may be a protein with a
very stabile structure perhaps due to many disulfide bridges. It is
also possible the substance does undergo structural denaturation tut
the active sites remain intact or reanneal after treatment. Although
the treatments had no effect on the activity of the suppressor
substance, and the substance was not removed from HCCM when filtered
through nitrocellulose which

binds

proteins

through

hydrophobic

interactions, we have not yet ruled out the possibility the suppressor
factor is a protein. The stability of its biological activity and the
fact that the HCCM suppressor factor is >30,000 MW

serve as evidence

that this horse suppressor substance is different from the proteins
that exhibit antiviral activity and that are responsible for maternal
recognition of pregnancy in sheep and cows. Both oTP-1 and bTP-1 are
of the alpha-interferon family (Imakawa et al., 1987; Stewart et al.,
1987; Charpigry et al., 1988) and like other alpha-interferons, are
<30,000 MW and unstable when treated with heat or repeated freezethawing. A porcine conceptus-derived interferon-like protein with
anti-viral activity has also been identified, and it too is small
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(22,000-24,000 Mr) and extremely labile (Cross and Roberts, 1989). We
therefore conclude that the suppressor factor described herein is most
likely not of the interferon family.
We have suggested that if the conceptus-derived suppressor
substance plays a significant role in protecting the conceptus from
maternal immunological assault, the inability of it to cross-react
with lynphocytes of another species could in part explain the failure
of interspecies pregnancies. It has been shown with sheep and goats
that medium conditioned by 20-day old conceptuses exhibited greater
suppressive activity when added to lynphocytes of the same species as
compared to that seen when added to lynphocytes interspecifically
(Roth and White, 1989). The lack of immunosuppressive capacity of
conceptus-derived products of one species in the maternal environment
of another species could explain the repeated failure of sheep/goat
interspecies pregnancies and the apparent evidence of inmunological
rejection of the conceptus.
Horses and donkeys provide a unique model for the study of
interspecies cross-reactivity of conceptus-derived substances because
both interspecies and hybrid pregnancies are successful. We show
herein that there is no difference in overall suppressive activity of
HCCM

when

added

to

donkey

lynphocytes

as

compared

to

horse

lymphocytes. Thus, it is possible that the horse conceptus-derived
suppressor factor does efficiently cross-react with donkey lynphocytes
and this may explain, in part, how donkeys are able to carry horse
fetuses to term. When added to goat lynphocytes, however, HCCM is much
less suppressive indicating that with more distantly related species
the HCCM

suppressor

factor

is not

as

efficient

at

inhibiting
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lymphocyte proliferative responses. Furthermore, both donkey and horse
lymphocyte suppressor curves followed quadratic functions with the
same slope indicating that the mechanism of action of the suppressor
substance in HCCM is similar on lynphocytes of the two species. With
the much less-related caprine species, the HCCM suppressor substance
appears to be acting in a different manner resulting in a suppressor
curve that follows a linear function. Although it is suppressive, HCCM
is much less suppressive when added to lynphocytes of the caprine
species, and also appears to foe suppressing the lynphocytes through a
much less effective mechanism. Although these data provide evidence
for

species-specific

activity

of

HCCM,

we

cannot

ignore

the

possibility that goat lynphocytes may be inherently more difficult to
suppress than equine lynphocytes when stimulated with FWM.
In summary, we have found that from day 9 through day 26 of
development the equine conceptus produces an irmtunosuppressive factor
that inhibits in vitro horse lymphocyte proliferation in a non-antigen
specific manner. The suppressor factor appears to be >30,000 MW and
maintains full biological activity after repeated freeze-thaw and
after heating to 90°C for 30 minutes. This substance exhibits its
suppressive

effect

in

a

similar

manner

on

donkey

and

horse

lymphocytes, yet on lymphocytes of the less-related goat species,
suppressive activity is significantly decreased. These data indicate
that the substance is, to seme degree, species-specific. Determining
the significance of this immunoregulatory substance in maintaining the
conceptus, and its possible relationship to successful interspecies
pregnancies

should

help

in

our

understanding

phenomenon of fetal allograft survival.

of

the

puzzling

P G E 2 -INDEPENDENT
HORSE

CHAPTER IV
IMMUNOSUPPRESSIVE ACTIVITY
TROPHOBLAST TISSUE3

OF

INTRODUCTION
Suppression of the maternal
maternal

interface may

be

immune response at the fetal-

imperative

allogeneic conceptus during pregnancy.

for

the

survival

of

the

Irrmunosuppressive factors

associated with placental and/or uterine tissues and their secretions
have been reported for several species, including mice (Clark et al.,
1985,1986; Chaouat, 1987), humans (Daya and Clark, 1986; Pockley et
al., 1988), sheep (Segerson et al., 1984; Hansen et al., 1987; Murray
et al., 1987; Roth et al., 1991), goats (Roth et al., 1991), pigs
(Murray et al., 1978), cows (Roberts, 1977; Segerson and Gunsett,
1990; Segerson and Libty, 1990) and horses (Roth et al., 1990).

In

addition, immune cells with suppressor activity accumulate in and
around the placenta (Slapsys and Clark, 1982,1983; Clark et al., 1983;
Brierley and Clark, 1985; Uren and Boyle, 1990).

Both placental

suppressor cells and decidual cells, produce the immunosuppressive
prostaglandin,

FGE2

(Scodras

et

al.,

1990).

Likewise,

early

developing embryos of several species produce FGE2 (Lacroix and Kann,
1982; Pakrasi and Dey, 1982; Hwang et al., 1988; Holmes et al., 1990).
PGE2 suppresses IL-2 production by T lynphocytes (Rappaport and Dodge,
1982; Walker et al., 1983) and induces T suppressor cells (Chouaib and
Fradelizi, 1982; Delfraissy et al., 1982; Kaszubowski and Goodwin,
1982).

Therefore, it has been suggested that PGE2 is an important

immunosuppressant of pregnancy. The fact that PGE2 from decidual cells
3 Roth, T.L., K.L. White, D.L. Thompson, Jr. and D.W. Horohov. J. Reprod. fcnunol.
(In review).
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and decidual macrophages inactivates T lymphocytes (Parhar et al.,
1989) and natural killer (NK) cells in the decidua, (Scodras et al.,
1990) supports the theory that PGE2 activity is conducive to fetal
survival (Lala et al., 1990).
We reported that horse conceptus-conditioned medium suppresses
in vitro lymphocyte proliferation in vitro (Roth et al., 1990).

The

specific objective of this study was to determine if indomethacin, a
prostaglandin

inhibitor,

could

reduce

horse

trophoblast-derived

immunosuppressive activity.
MATERIALS AND METHODS
Animals

and

conceptus

collections.

Conceptuses were

obtained from mares on day 21 of gestation according to procedures
described in Chapter III.

The flushing medium consisted of sterile

PBS supplemented with 1% penicillin/streptomycin (Gibco, Grand Island,
NY).
Conceptus cultures.

Three conceptuses, each from a different

mare, were obtained on day 21 of gestation.
conceptuses were rinsed twice with PBS.

Under sterile conditions,
Both the embryonic capsule

and the fetus proper were removed from the trophoblast tissue of each
conceptus.

The trophoblast tissue was cut into two approximately

equal sections and each section was rinsed twice in sterile RFMI-1640
medium supplemented with 1% antibiotic/antiirycotic

(RFMI).

Each

trophoblast section from each conceptus was randomly assigned to 2
treatments.

For treatment 1, each tissue section was placed in a

tissue culture flask (25 cm2) containing 5 ml RFMI.

Treatment 2

tissue sections were each placed in a flask with 5 ml RFMI containing
1 x 10-4 M indomethacin (Sigma, St. Louis, MD).

An additional flask
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was set up with 5 ml

indomethacin control medium

(I-CM)

which

consisted of RFMI with 1 x 10-4 M indomethacin but no trophoblast
tissue.

A total of 6 trophoblast tissue cultures (3 in RFMI and 3 in

RIMI + indomethacin)

and a seventh

incubated for 28 h at

37°Cin a humidified atmosphere of

air.

Following

incubation,

horse

flask containing

I-CM were
5% CO2 and

trophoblast-conditioned medium

(HTCM) and indomethacin-treated trophoblast-conditioned medium

(I-

HTCM) were obtained by first pouring the contents of each flask into a
conical tube and then centrifuging the tubes at 1,500 x g for 10 min.
Supernatants were filtered through a .2 pm filter and were stored in 1
ml aliquots at -80°C.

Following centrifugation, the tissue volume in

each culture was determined.

The volume was consistent, measuring

approximately 100 pi of tissue in each culture.

I-CM was similarly

aliquoted and stored at -80°C.
Lymphocyte

proliferation

assay.

Peripheral

lynphocytes were obtained as described in chapter III.
carried out

in quadruplicate

culture-treated plates.

in

96-well,

Cultures were

round-bottomed

tissue

Non-stimulated control cultures contained 25

pi cell suspension (1 x 105 cells) and 75 pi EFMI+.
control wells received

blood

Stimulated

25 pi cells, 25 pi RFMI+ containing 0.1 pg

pokeweed mitogen (PWM) and 50 pi RFMI+.

Treated cultures received 25

pi cells, 25 pi RFME+ with 0.1 pg EVM and 2.5, 5 or 10 pi of HTCM
(n=3), I-HTCM (n=3) or I-CM (n=l) diluted in 50 pi RFME+.

All

cultures were

PBL

carried out

simultaneously with

the

same

populations and the final volume of each well was 100 pi.

3

Cultures

were maintained in an incubator at 37°C in a humidified atmosphere of
5% CO2 and air.

3H-thymidine was added to the culture (lpci/well) 99 h
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after the start of culture and cells were harvested 15 h later.
Radioactivity on

glass

fiber

filters was

determined

fcy liquid

scintillation counting.
Radioimmunoassay.

The

radioimmunoassay

(RIA)

used

to

quantify PGE2 in each HTCM and I-HTCM sample was conducted according
to published procedures (Hwang et al., 1975; Hwang, 1985). ^h-pge2
(100-200 Ci/mmol) used in the RIA was obtained from DuPont NEN
Research Products (Boston, MA). An aliquot of HTCM from one conceptus
was

divided

into

microconcentrator.

two

fractions

using

a

30,000

MW

cut-off

The retentate fraction (>30,000 MW) was diluted

back to its original volume with RFMI and the concentration of PGE2
was determined. A

sample of RFMI served as a control for any

background interference that might be associated with the culture
medium.
Statistical Analysis.

Average cpm for quadruplicate wells of

the lymphocyte proliferation assay were calculated and the results
analyzed by AN3VA using the general linear model procedures of the SAS
computer

package

(Luginbuhl

et

al.,

1985).

To

determine

immunosuppressive activity, lymphocyte proliferation in I-CM, HTCM and
I-HTCM treated cultures was compared to that in stimulated control
cultures using Tukey's mean comparison tests.

Similarly, Tukey's mean

comparison tests were used to determine within treatment differences
between the addition of 2.5, 5 and 10 (ll/well of I-CM, HTCM and IHTCM.
RESULTS
Lymphocyte

proliferation

assay.

The

lymphocyte proliferation assay are shown in Fig. 7.

results

of

the

Each data point
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Figure 7. The effect of indomethacin control medium (I-CM),
horse
trophoblast-conditioned
medium
(HTCM)
and
indomethacin-treated HTCM (I-HTCM) on PWM-stimulated horse
PBL proliferation.
Different
superscripts
designate
differences in lymphocyte proliferation (P<.01). Stimulated
control values (150,000 ± 25,000 cpm; mean ± SEM) did not
differ
(P>.05)
from those of I-CM-treated cultures.
Lymphocyte proliferation was less (Pc.01) in both HTCM and
I-HTCM treated cultures as compared to that in stimulated
controls.
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represents the mean ± SEM

(cpm) for three lymphocyte populations

treated with I-CM (n=l), HTCM (n=3) and I-HTCM (n=3).

FWM-stimulated

lymphocyte proliferation in HTCM and I-HTCM treated cultures was less
(Pc.Ol) than that in I-CM-treated or stimulated control cultures.
Proliferation in I-CM-treated cultures did not differ (P>.05) from
that in stimulated control cultures. Immunosuppressive activity of
HTCM and I-HTCM did not differ
treatment

comparisons

proliferation with

the

(P>.05).

indicated
different

no

Results of the within
differences

quantities

of

(P>.05)

HTCM

and

in
I-CM.

However, the addition of 10 *11 of I-HTCM suppressed lynphocytes more
(P<.05) than the addition of 2.5 *ll I-HTCM.
Radioimmunoassay.

The concentration of PGE2 in each sample of

HTCM and I-HTCM, as determined fcy the FGE2 RIA, are shown in Table 4.
The effectiveness of indomethacin,

as

a

PGE2

inhibitor

in

the

trophoblast cultures, was determined fcy comparing the concentration of
PGE2 in I-HTCM to that in HTCM for each trophoblast sample.

Addition

of indcmethacin to horse trophoblast cultures reduced PGE2 production
fcy 91 ± 1.6%.

Not shown in Table 4 are the data for the >30,000 MW

fraction of HTCM (Tissue sample 1) which was 38 pg/ml PGE2 .
DISCUSSION
The results of this study indicate that PGE2 is not the primary
factor responsible for horse trophoblast-derived immunosuppressive
activity.

Our results differ from what has been reported for decidual

type placentae of humans and mice where PGE2 appears to play a
critical role in the suppression of immune cells at the fetal-maternal
interface.
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TABLE 4.
PGE 2 concentrations (ng/ml) in horse
trophoblast-conditioned medium (HTCM) and
indomethacin-treated HTCM (I-HTCM)a .
Trophoblast
tissue sampleb

%

Decrease0

HTCM

I-HTCM

1

18.56

1.33

93

2

4.46

.50

89

3

15.02

1.42

91

Mean ± SEM

12.68 ± 7.4

1.08 ± .53

91 ± 1.6

aThe RPMI control value was 0.00 pg/ml.
trophoblast was obtained from day 21 horse conceptuses.
Tissue sections from each trophoblast sample were cultured
in RPMI and RPMI + indomethacin to generate HTCM and I-HTCM,
respectively.
t h e inhibitory effect of indomethacin on PGE2 production
was calculated using the equation (1 - I-HTCM/HTCM x 100).
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In the murine species, decidua contain T lynphocytes of several
subsets

(Kearns and Lala, 1985) as well as natural killer cells

(Scodras et al., 1985).

Excessive NK cell infiltration into the feto

placental unit appears to be responsible for spontaneous abortion of
specific murine pregnancies

(Gendron and Baines,

1988).

During

successful murine pregnancies, suppressor cells in the decidua and
decidual cells themselves, inactivate NK cells (Crcy et al., 1985;
Gambel et al., 1985; Scodras et al., 1990).

Recently, it has been

shown that NK cell suppression is mediated fcy PGE2 , and the addition
of indomethacin (10-5 M) or anti-PGE2 antibody revives NK activity in
the decidua (Scodras et al., 1990).

Additional in vivo evidence

concerning the significance of PGE2 in maintaining pregnancy was
provided fcy Lala et al.

(1990),

who

demonstrated

that

chronic

administration of indomethacin to pregnant mice causes abortion and
embryo resorption.
Similar to murine placentae, first trimester human placentae
contain decidual cells and decidual macrophages that secrete PGE2
which, in turn, inhibits T lymphocyte activity fcy blocking expression
of the interleukin-2 receptor and

inhibiting

the

production of

interleukin-2 (Lala et al., 1988).

However, in agreement with our

findings, Uren and Beyle (1990) demonstrated that suppressive activity
of human placental macrophages was not inhibited fcy indomethacin.
Additionally, Scodras et al. (1990) found that the concentration of
PGE2 in murine decidual cell supernatants following 20-hr in vitro
culture was much lower than that required for NK cell suppression
induced fcy decidual cells.

The authors suggested that, in addition to

FGE2 , decidual cells produce other suppressor molecules.

Our data
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support this theory. While indomethacin effectively decreased PGE2
production, immunosuppressive activity of HTCM and I-HTCM did not
differ, thus it appears there are factors other than PGE2 responsible
for the immunosuppressive activity in HTCM.
surprising in view of

the

fact

that

These results are not

conceptus-derived

soluble

suppressor proteins have been identified in a number of species (Clark
et al., 1986; Daya et al., 1986; Murray et al., 1987).
There are three additional pieces of evidence supporting our
conclusion

that

immunosuppression.

PGE2

is

not

responsible

for

HTCM-induced

First, PGE2 is capable of inhibiting 3H-thymidine

incorporation fcy mitogen-stimulated lymphocytes at concentrations of
10-8 M, but to attain at least 65% suppression, a concentration of 10-7
M is required (Goodwin et al., 1977).

In this study, we achieved 65%

suppression of lymphocyte proliferation with PGE2 concentrations in
the

lymphocyte

culture

wells

ranging

from

10-9

to

10-11 m.

Furthermore, it has been reported that PGE2 does not inhibit FWMstimulated peripheral blood lymphocytes (Goodwin et al., 1977).

Yet,

in this study and in previous work (Roth et al., 1990), we have
demonstrated potent suppression of FWM-stimulated horse PBLs with
horse conceptus-conditioned medium.
that

following

amicon

Finally, we previously reported

microconcentrator

centrifugation,

the

immunosuppressive activity of horse conceptus-conditioned medium is
contained in the >30,000 MW retentate fraction (Roth et al., 1990).
While in that report we mentioned the apparent lack of hormone or
prostaglandin contribution to the suppressive activity, we could not
rule out the possibility that these substances retained in the >30,000
MW fraction.

In this study, we determined that a single passage
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through the microconcentrator reduced the PGE2 concentration of the
retentate fraction fcy 99.7% relative to that of the whole sample.
Together, data from previous work indicating the large size of
the horse conceptus-derived suppressor factor(s) (Roth et al., 1990)
and

from this

study

in which the

inhibition of

prostaglandin

production did not affect suppressor activity of cultured horse
trophoblast, indicate that PGE2 is not the primary immunosuppressant
produced fcy the pre-irrplantation horse conceptus.

CHAPTER V
HORSE CONCEPTUS-DERIVED SUPPRESSION OF
T AND B LYMPHOCYTE PROLIFERATION!INTERLEUKIN-2
RECEPTOR INVOLVEMENT4
INTRODUCTION
The immunosuppressive activity of a >30,000 molecular weight
(MW) factor present in horse conceptus conditioned medium (HCCM) has
previously been reported (Roth et al., 1990). Results from subsequent
work have shown this suppressor factor (HCCM-SF) to be >100,000 MW.
High molecular weight components of conceptus cultures and/or gravid
uterine fluid of other domestic species, including the cow (Segerson
and Bazer, 1989), sheep (Hansen et al., 1987; Murray et al., 1987) and
pig (Murray et al., 1987), also suppress lynphocytes when supplemented
to in vitro blastogenesis cultures. It has repeatedly been suggested
that these suppressive factors play a role in protecting the conceptus
from maternal irrmunological attack during pregnancy. In the horse, one
such role may be to temporarily protect the endometrial cups which,
although surrounded by lynphocytes, are not destroyed until day 120 of
pregnancy

(Allen, 1979). Thus far, most investigations have been

primarily directed towards identifying and characterizing uterine and
conceptus-derived factors (Murray et al., 1978; Godkin et al., 1982;
Hansen et al, 1987; Newton et al., 1988; McDowell et al., 1990) while
their functional significance remains largely unknown.
Seme information pertaining to the immunosuppressive mechanisms
of components obtained from uterine fluid or conceptus tissue has been
4 Roth, T.L., K.L. White, D.L. Thcrpson, Jr., S. Rahmanian and D.W. Ifordhov. J.
Reprod. Fertil. (In review).
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reported for humans (Pockley and Bolton, 1990; Saito et al., 1990),
mice (Clark et al., 1985; Mayumi et al., 1985; Clark et al., 1986),
sheep (Segerson, 1988) and, more recently, cows (Segerson and Libfcy,
1990).

In these studies,

lymphocyte

cultures

as

suppressor activity was
decreased

following mitogen stimulation.

^H-tbymidine

identified

uptake

fcy

in

cells

There are mitogens available that

stimulate B and/or T lynphocytes preferentially (Sharon, 1983), but in
most immunosuppressive studies only PHA, a potent T cell activator,
has been used to stimulate lymphocyte proliferation. Because cellmediated and not humoral immunity is of greater concern in fetal
allograft acceptance, T cells have been the focus of most attenpts to
elucidate suppressor factor mechanisms.
Production of IL-2 and the expression of the high affinity IL-2R
are critical for proliferation of T cells in response to either PHA or
antigen (Depper et al., 1984). The IL-2R has been identified and
described as a dimer consisting of a p55 alpha chain with low affinity
for IL-2 and a p75 beta chain with slightly greater IL-2 affinity
(Greene et al., 1986; Tsudo et al., 1986; Teshigawara et al., 1987;
Smith, 1988). With mitogenic or allogeneic stimulation, the two chains
are expressed together on the cell surface to form the high affinity
IL-2R conplex which, when bound to IL-2, is largely responsible for
signaling cell proliferation

(Sharon et al.,

1986; Smith,

1988).

Recombinant human IL-2 (rIL-2) will interact with the IL-2R of many
species, including the horse (Fenwick et al., 1988). An antibod/ to
the IL-2R (anti-Tac) blocks IL-2 binding (Robb et al., 1981; Leonard
et al., 1982; Sharon et al., 1986), inhibits cell proliferation (Robb
et al., 1981) and may even prevent allograft rejection (Kirkman et
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al., 1985). Data have suggested that uterine/conceptus suppressor
factors act similarly,

disrupting the

IL-2/IL-2R

interaction

to

inhibit blastogenesis. A soluble suppressor factor obtained from mouse
decidua blocks the response of T cells to IL-2 by interfering with IL2R (Clark et al., 1985; Clark et al., 1986). Pregnancy zone protein
reduces IL-2 production but not IL-2R expression (Saito et al., 1990).
Human placental supernatant inhibits both
proliferation of CTLL-2 cells

IL-2

and

IL-4

(Menu and Chaouat, 1989),

driven
an IL-2

dependent murine cell line (Gillis et al., 1978). Suppressive activity
of substances found in uterine luminal fluid of pregnant sheep and
cows may also be mediated through alterations of the IL-2 system. In
both species, uterine fluid suppressor factors block IL-2 mediated
blastogenesis of T cells (Segerson, 1988; Segerson and Gunsett, 1990),
and it has been suggested that bovine uterine luminal proteins act by
blocking IL-2R recognition in addition to binding directly to IL-2
(Segerson and Libby, 1990).
While mitogen-stimulated lymphocyte proliferation assays have
provided valuable information about the in vitro response of these
cells to immunosuppressive factors, the response of specific cell
subsets has not been determined. Antibodies to unique cell subset
antigens (CD4, CD5 and CD8) are available for labeling specific cell
populations. Human T cells express many cell surface molecules such as
the CD5 molecule which is present on virtually all T cells (Hedrick et
al., 1984). The T cell population can be divided into two broad
subsets,

T

helper

and

T

suppressor/cytotoxic

expression of CD4 and CD8 antigens,

cells,

respectively

by

(Sprent,

their
1989).

Similarly, there exist antibodies to equine lymphocytes that bind
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either the entire T cell population or a T suppressor cell subset
(Wyatt et al., 1988). Specific fluorescent antibody labeling followed
by fluorescence activated cell sorter (FACS) analysis provides an
accurate

method

for

iirmunophenotypically

distinguishing

quantifying cell subsets in a mixed cell population

and

(Jackson and

Warner, 1986).
The experiments described herein were designed

1) to examine

the affect of HCCM-SF on B and T lymphocytes using various mitogens
and FACS analysis

2) to determine the temporal relationship of HCCM-

SF activity and lyitphocyte activation and

3) to better define the

proposed IL-2 associated mechanism of lymphocyte suppression. The
results of these experiments may increase our understanding of the
fetal-maternal immunological interaction in utero.
MATERIALS AND METHODS
Animals and Concept us Cultures.

The horse breeding regimen

and conceptus collection techniques were carried out as described in
Chapter III.

Conceptuses were collected fcy non-surgical uterine

flushing on Day 20 (ovulation = Day 0) using sterile PBS supplemented
either with 1% calf serum and 1% antibiotic/antimycotic (Group I), or
with

only

1%

antibiotic/antirrycotic

(Group

II).

Under

sterile

conditions, conceptuses were rinsed twice in their respective medium,
after which Group I conceptuses were rinsed once in RIMI+, and Group
II conceptuses were rinsed in RTMI-1640 with 1% antibiotic/antiirycotic
(RfMI). The three Group I conceptuses were each placed in a 50-ml
tissue culture flask containing 20 ml REMI+. Cultures were incubated
for 48 h at 37°C in a humidified atmosphere of 5% CO2 and air. The
three Group II conceptuses were each placed in a 50-ml tissue culture
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flask containing 15 ml REMI and were incubated for 30 h under the same
conditions described for Group I. Within both Group I and Group II,
conceptus culture supernatants (HCCM I and HCCM II, respectively) were
pooled. Both pooled samples were centrifuged
filtered

(600 x g; 20 min),

(.2 Jim) and stored in aliquots at -80°C.

A

lymphocyte

proliferation assay was used to determine that there was no difference
(p>.05) in suppressive activity between HCCM I and HCCM II (Table 5).
Control medium (CM) consisted of REMI or REMI+ incubated and stored
similarly.
For sane experiments, HCCM and CM samples were both fractionated
by molecular weight

using

microconcentrator

centrifugation.

Two

microconcentrators with 100,000 MW exclusion membranes were rinsed
with 500 |ll of REMI-1640 (850 x g; 50 min). After rinsing, 500 |il of
CM and HCCM were each pipetted into one of the microconcentrators.
Samples were centrifuged (850 x g; 40 min) and flow-through fractions
(<100,000 MW) were collected. Retentate fractions were resuspended in
500 |jll REMI-1640 and, again, centrifuged. Flow-through volumes were
discarded. Retentate was resuspended to 500 |il, the centricons were
inverted and the retentate fractions (>100,000) were collected off the
filter membranes into the collection cups by centrifugation (600 x g;
5 min). Both fractions of CM and HCCM were filtered (.2 pm) and
diluted to 600 pl/ml in RFMI+.
Lymphocyte Proliferation Assays.

Unless otherwise stated,

the lymphocyte proliferation assays were carried out as follows.
Lymphocytes were obtained according to procedures described in Chapter
III. Cultures were prepared in quadruplicate for each PEL population
in 96-well round-bottomed tissue culture-treated plates and each well
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TABLE 5.
stimulated

The effect of
lymphocytes.a

Volume added
(Jll/well)
0 (control)
1
5
10

HCCM

I and

HCCM

HCCM
44
36
22
15

41
32
20
12

± 8b
± 4c
± 3cd
± 26

aValues represent mean
lymphocyte populations.

cpm

bcdepifferent superscripts
Tukey mean comparisons).

-±- SEM

designate

±
±
±
±

II

on

PWM-

II
7b
4c
icd
le

(x 10“3)

for

differences

three
(p<.05;
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received 1 x 10^ cells (25 Jil). EWM, diluted in REMI-1640, was added
to stimulate cell proliferation (.1 |xl PWM/well). HCCM or fractionated
HCCM was added in concentrations specified for each assay, and final
well volume was 100 |ll. The assays were completed as described in
Chapter III.
Preliminary Assay.

To determine the concentrations of PHA

required to induce optimal and sub-optimal proliferative responses in
our lymphocyte assay,

three.populations of PBLs were tested with

serial

PHA

dilutions

of

(3

to

.0625

jil/well). Maximal

cell

proliferation was achieved using 1 (ll/well while a suboptimal response
(approximately 50% of maximum) resulted from the use of .125 jil/well
(Fig. 8).
Mitogen Comparison Assay.

The suppressive activity of HCCM

II on LPS-, PHA- and FWM-stimulated lymphocytes was compared. HCCM II
was serially diluted in RFMI+ such that treated wells contained HCCM
II at 20 to 1.25 % of total volume while control wells received only
RTMI+. FWM (4 (ig/ml), PHA (5 ill/ml) and LPS (.4 Jig/ml) were added to
wells in 25 (ll volumes. In our lab, these concentrations of LPS and
PWM stimulate maximal proliferation of equine lymphocytes. PHA was
added at a sub-optimal dose, one found to stimulate proliferation at
approximately 50% of maximum, in order to increase the sensitivity of
the PHA-treated cells to HCCM suppression. The three mitogen assays
were run simultaneously with PBLs from three randomly chosen mares.
PHA- and FWM-stimulated cultures were pulsed with ^H-thyrtddine at 80 h
and harvested at 96 h. LPS-stimulated cultures were pulsed at 96 h and
harvested at 112 h since we found LPS-treated cells require more time
to achieve their maximal proliferative response.
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Figure 8.
Serial dilutions of PHA were tested in an equine
lymphocyte proliferation assay to determine the PHA
concentrations required to induce optimal and sub-optimal
proliferative responses in our assay system.
Data represent
average cpm — SEM for three equine lymphocyte populations.
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Temporal Effect of HCCM.

To determine the stage of cell

activation with which HCCM-SF interferes, HCCM I was supplemented to
lymphocyte cultures 0, 24 and 48 h following EWM stimulation of cells.
The

lymphocyte

proliferation

assay

was

prepared

as

previously

described using lymphocytes from three randanly chosen mares. On the
96-well plate, triplicate rows were designated, Time 0, Time 24 and
Time 48. HCCM I was

serially diluted in RFMI+

to three final

concentrations of 480, 240 and 120 (ll/ml. Each of the Time 0 rows were
supplemented with a different dilution of HCCM I (25 (ll/well). After
24 h incubation, each of the three Time 24 rows received 25 (ll/well of
the same three HCCM I dilutions. At 48 h the three Time 48 rows were
similarly supplemented. At each treatment period, those wells not
receiving HCCM I received 25 (ll RFMI+ such that final volume in all
wells was 150 |ll. FWM was supplemented to all tut non-stimulated
control wells at Time 0. All wells were pulsed at 100 h and harvested
at 116 h. This experiment was carried out twice with a total of six
PEL populations,

and data from both experiments were pooled for

statistical analysis.
Cells were treated with HCCM II prior to mitogen stimulation to
determine if HCCM-treated lymphocytes are permanently suppressed. PBLs
from two mares were

prepared as

described

for

the

lymphocyte

proliferation assays. The pre-stimulated cultures consisted of four
treatments set up in sterile cryovials as follows:
- 150 J1.1 cells + 450 |il RPMI+

1) NOn-stimulated

2) Control - 300 (ll cells + 900 (ll

RPMI+ 3) HCCM 10 - 120 (ll HCCM II + 300 (ll cells + 780 (ll RFMI+ and
4) HCCM 5 - 60 (ll HCCM II + 300 (ll cells + 840 (ll RTMI+. Vials were
vortexed and incubated with loosened caps for 24 h. At the end of
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incubation, cells were washed twice in RFMI+ (400 x g; 10 min) and
resuspended at 2 x 10® cells/ml. Cells from each pre-stimulated
culture were pipetted into wells (50 (ll/well) and were treated with 25
^1 REMI+ containing 0 [ll (pre-treated only cells), 5 [ll (pre/post
treated 5 ) or 10 [ll (pre/post-treated 10) HCCM II. FWM was added to
all hut non-stimulated control wells at this time. Assay was completed
as previously described.
Equine Lymphocyte Supernatant

Supplementation.

Equine

PBMC supernatant (PEMCS) was generated fcy combining PBMEs from three
mares, diluting cells in RFMI+ to a concentration of 5 x 10®/ml (10 ml
total) in a tissue culture flask and adding 150 [ll PHA. After 6 h
incubation, the cell suspension was pipetted into a 15 ml centrifuge
tube and centrifuged (400 x g; 10 min). Medium was discarded and cells
resuspended in 10 ml

fresh RFMI+.

Cultures were then incubated for 18

h, cells were again

centrifuged (600 x g; 10 min) and

PEMCS was

obtained. Control medium consisted of

10 ml of

the same

RPMI+

incubated for 18 h in a tissue culture

flask. The PEM2S assay was

prepared with three lymphocyte populations. Two 96-well plates were
set-up with serial dilutions of HCCM II

(10 to .625 [ll/well). Cells

were added to wells (1 x 10® /well), and FWM was added to all but nonstimulated control wells. All wells of one plate received 50 [ll PEMCS
while all wells of the second plate received 50 [ll CM. After 24 h of
culture, wells received another 40 [ll of

their respective medium

bringing total well volume to 150 [ll. The assay was completed as
previously described.
IL-2

Supplementation.

The effect of supplementing HCCM-

treated equine lymphocytes with recombinant human interleukin-2 (rIL-
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2; Cetus Corp., Emeryville, CA) was examined in two assays

designed

to determine if supplementation of rIL-2 to BCCM-treated lymphocytes
would override the suppressive effect of HCCM. PBLs from three mares
were used. In the first experiment, two sets of quadruplicate wells of
each PEL population were supplemented with 3, 6, 12 and 24 p.1 of HCCM
I. One set of each quadruplicate pair also received rIL-2 (200 U/ml).
PHA (.125 fil/well) was added to all wells, cells were pulsed at 80 h
and harvested at 96 h.
In the second experiment, HCCM II was diluted in RRyH-s- to 600
|il/ml

and

supplemented

to

cultures

in

25

|il volumes.

Cell

proliferation was stimulated with a sub-optimal dose of PHA (.125
^ll/well). Serial dilutions of rIL-2
supplemented to cultures.

(50 to .78 U/ml)

were also

To serve as a negative control,

non-

stimulated cells were similarly supplemented with rIL-2. The positive
control consisted of cells, PHA and rIL-2, but no HCCM. Cultures were
pulsed at 80 h and harvested at 96 h.
CTLL-2

Cells.

tftilike resting lynphocytes,

CTLL-2

cells

continuously express the high affinity IL-2R complex, and the addition
of small concentrations of IL-2 will immediately stimulate these cells
to proliferate, while a deficiency of IL-2 will lead to their rapid
demise (Gillis, 1978). To better understand the effect of HCCM on IL2R function, fractionated HCCM II was added to CTLL-2 cell cultures.
Triplicate wells of a 96-well plate were prepared with seven serial
dilutions of rIL-2 (50 to .78 U/ml) to serve as a standard. In each of
the

following

rows,

rIL-2

was

added

to

triplicate

wells

at

concentrations identical to those in dilutions 3-6 of the standard
(12.5 to 1.56 U/ml). Each of these rows also received 50 pl/well of
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one of the two diluted fractions of HCCM II or CM. The standard wells
received 50 jxl REMI+. CTLL-2 cells were added to all wells

(2,000

cells in 50 |il) and cultures were incubated for 24 h before cells were
pulsed with ^h-thymidine (1 jiCi/well). Cultures were harvested 4 h
after pulsing and radioactivity was determined by liquid scintillation
counting.
Murine

Splenocytes.

Mouse splenocytes were obtained from

spleen homogenate by Ficoll-gradient centrifugation and interface
cells were

recovered.

Cells

were

rinsed

twice

with

HBSS

and

resuspended in RIMI+ at 7 x 10^ cells/ml. Splenocytes were added to
two 96-well plates in 25 p.1 volumes and were stimulated by the
addition of 50 fll of FWM,

PHA or Con A

respectively). Fractionated HCCM II was

(5, 2.5 and 5 Jig/ml,

supplemented to treated wells

of one plate (20 (Xl/well), while stimulated control wells received 20
(i,l of each CM fraction. Cells were pulsed at 88 h and harvested at 100
h.
FACS Analysis.

FACS analysis was used to determine the effect

of HCCM II on proliferation of specific lymphocyte subsets. HCCMtreated cell populations were compared to non-treated cells using
three antibodies to different equine lymphocyte markers. Antibodies
were, the monoclonal antibodies (mAb) HT23A and HT14A (pan T and T
suppressor cell subset antibodies, respectively;

VMRD, Pullman, WA),

and an FITC-conjugated polyclonal goat anti-equine IgG antibody (B
cell antibody). The conjugate for the mAbs was an FITC-conjugated goat
anti-mouse

IgG

antibody

(VMRD,

Pullman,

WA).

Two

equine

PEL

populations were analyzed. For each population, five tissue culture
flasks were prepared as follows:

1) Control - 4 ml RPMI+

2) PHA -

6.25 |ll PHA + 4 ml RRH+

3) FWM - 20 |Xl

+ 4 ml RPMI+

6.25 |ll PHA + 500 |ll HCCM II + 3.5 ml RBMI+

4) PHA+ -

5) FWM+ - 20 |ll PWM + 500

|ll HCCM II + 3.5 ml RTMI+. To each flask, 1 ml of cells suspended in
RPMI+ at 5 x 1q 6 cells/ml was added. Flasks were incubated for 96 h
and, using a hemacytometer, cell concentration was determined at the
end of culture. The cell suspension in each flask was divided into
five

sterile

tubes

(1

ml/tube).

Tubes

were

labeled

as:

autofluorescent control, FITC control, mAb HT23A, mAb HT14A and IgGFITC. Cells were pelleted (400 x g; 10 min)

and medium was decanted.

Cells were rinsed with 3 ml volumes of PBS and decanted again. The
monoclonal antibodies, HT23A and HT14A, were diluted 1:1000 in PBS
supplemented with 10% goat serum (PBS-GS). The polyclonal goat antiequine IgG-FITC

and goat anti-mouse IgG-FITC antibodies were diluted

1:400 in PBS-GS. Diluted antibodies were added to appropriate tubes
(50 |ll/tube) while autofluorescent and FITC controls received 50 |ll
cold PBS-GS. Tubes were vortexed and incubated on ice for 1 h. All
samples were washed with 3 ml volumes of ice cold PBS-GS. After
decanting, 75 |ll cold 1% p-formaldehyde was added to IgG-FITC tubes to
fix cells. Tubes were vortexed and stored at 4°C. All remaining tubes,
except the autofluorescent controls, received 50 |ll of diluted goat
anti-mouse IgG-FITC. Autofluorescent controls received 50 |il PBS-GS.
After vortexing, cells were incubated on ice 1 h, then washed and
fixed as described for cells in IgG-FITC tubes. Samples were stored at
4°C for 48 h then diluted with 100 |il PBS-EDTA and analyzed on a FACS
440 (Becton Dickinson, Mountain View, CA). For each sample, 10,000
cells were analyzed for both fluorescence and light scatter using a
Consort 40 analyzer

(Becton Dickinson,

Mountain View,

CA). Gate

settings were determined based on autofluorescent and FITC controls to
eliminate any non-specific and/or background fluorescence. Due to
between-flask variation in cell concentration following the 96 h
culture, data were recorded herein as average cell number/ml (final
cell concentration in flask x % of 10,000 labeled) such that results
for a specific cell population would not be biased by a change in the
size of other cell subset populations. The two-dimensional scatter
analysis

was

used

to

conpare

treatments. The percent blast

blast

cell

populations

between

cells was determined by comparing

stimulated to non-stimulated FITC control sairples. Gates were set such
that the windowed area contained the larger cells present only in the
stimulated sairples. A window with the same gate settings was then
applied to the HCCM-treated, stimulated sairples, and the percentage of
cells (blast cells) in this area was recorded.
Statistical Analysis.

Average cpn and percent of stimulated

control values were calculated for triplicate or quadruplicate wells
of proliferation assays. Statistical analysis was performed using data
recorded as cpn if the stimulated control values were the same for the
treatments being tested. If the stimulated control values differed
between treatment groups, data were expressed and analyzed as % of
stimulated control. Results, in the appropriate form for each assay,
were analyzed in a factorial arrangement by AM3VA using the general
linear model procedures of the SAS coirputer package (Luginbuhl et al.,
1985). All main effect interactions were tested (i.e. treatment or
time x HCCM

or rIL-2 dose). Between treatment groups and within

treatment differences were determined by Tukey mean comparison tests.
To further compare the effect of rIL-2 on HCCM-treated cells to that
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on non-treated cells, regression analysis was carried out with data in
each of the two rIL-2 supplementation assays. Treatment curves were
compared and tested for differences in intercepts, linear functions
and quadratic functions, and insignificant terms were dropped from the
model.
RESULTS
Mitogen Comparison.

The effect of HCCM-SF on lymphocyte

cultures differed (pc.Ol) depending on the mitogen used to stimulate
lymphocyte proliferation (Table 6). The results of a 3 x 6 factorial
arrangement AN3VA and Tukey mean comparisons showed that, compared to
stimulated controls,

the percent suppression of HCCM-treated cell

proliferation was greater (p<.01) in FWM-stirnulated cultures than in
LPS- and PHA-stimulated cultures. PHA-stimulated cells were suppressed
(pc.Ol) by high concentrations of HCCM (10 and 20 (i.l/well), but LPSstimulated cells were unaffected (p>.05) at all levels of HCCM (within
mitogen Tukey mean comparisons).
Temporal Effect of HCCM.

Suppressive activity of HCCM-SF

decreased (pc.001) if HCCM I was supplemented to lymphocyte cultures
after the start of stimulation (Fig. 9). Although still suppressive,
HCCM added to cultures 24 h after the start of stimulation was less
(pc.Ol) effective then if added at Time 0. By 48 h following cell
stimulation, the addition of HCCM to the cultures resulted in only a
slight decrease in proliferation, much less (pc.Ol) than that observed
when HCCM was added at Time 24. There were no main effect interactions
(p>.05).
Lymphocytes pre-treated with HCCM II exhibited the capacity to
respond maximally to mitogen stimulation (Fig. 10). Proliferation of
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TABLE
6.
Effect
mitogen-stimulated

of
HCCM
II
lymphocytes3 .

....... —

'

LESE

-

8,990 ± 322

HCCM (fil/well)
0 (Control)
1.25
2.5
5
10
20

21,184 ± 2,713
20,180 — 3,553
19,446 ± 788
18,799 ±1,420
20,700 ±1,117
19,187 ± 682
mean

to

.MiilrOffSlI— .—-.

Non-Stimulated

aValues represent
populations.

supplementation

___EB2£___
5,657±

578

__ ESZtiEl—
14,712 ± 843

76,648±
18,13177,111± 19,572
72,660±
17,78963,138± 13,418*
72,762 ± 16,364
43,365 ± 9,260*
68,037 ± 14,010
30,595 ± 5,274*
58,726 ± 13,552* 22,271 ± 2,677*
48,905 ± 11,160* 12,155 ± 1,094*

cpm ±

SEM

for

three

lymphocyte

k cc*Different superscripts designate between mitogen
differences in overall suppressor activity (p<.01) as
determined by Tukey mean comparisons using data expressed as
% of control.
There was a significant mitogen x HCCM
interaction (pc.Ol).
*Differs from control
comparisons.

(p<.01); within mitogen Tukey mean
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Effect of HCCM I supplementation to PWMstimulated lymphocyte cultures at 0, 24 and 48 hours after
the start of culture.
Values represent mean % of
stimulated control i SEM for between lymphocyte population
variation (n=6). Different superscripts denote an overall
difference in suppression between times (p<.01; Tukey mean
comparisons). There were no significant interactions
(p>.05) .

99

80000

E3
□
■

Pre-treated
Pre-Post trt.
Control

T '

0)
3

60000 -

<u

40000 -

C

(A
C

■w

3
O
O

20000

-

P
I

I

1o

HCCM (jal/well)
10.
Response to PWM-stimulation following pre
incubation of cells with HCCM II.
Values represent mean
cpm i SEM for two lymphocyte populations.
Compared to the
stimulated control (no HCCM), there was no difference
(p>.05) in the proliferative responses of HCCM I pre
treated cells, while the responses of pre/post-treated
cells were suppressed (pc.Ol).
Different superscripts
denote differences in ^H-thymidine incorporation (pc.Ol;
Tukey mean comparisons).

Figure

100

cultures pre-treated with 5 or 10 jXl HCCM/well did not differ (p>.05)
from that of the stimulated control.

However,

the proliferative

response of pre-treated cells to which 5 and 10 (Xl/well HCCM was again
added during mitogen stimulation (pre/post-treated), was much less
(pc.Ol)

than that of both the pre-treated only

cells

and

the

stimulated control.
Equine Cell Supernatant and IL-2 Supplementation.

FHA-

stimulated PEMC supernatant was added to HCCM II-treated equine
lymphocytes in an atterrpt to augment their proliferative response to
EWM

(Fig. 11), but compared to proliferation in control medium-

supplemented cultures, there was no difference (p>.05). The addition
of an extremely high concentration of rIL-2 (200 U/ml) to HCCM Itreated cells did not override the suppressive activity of HCCM I
(Fig. 12). Although proliferation in cultures supplemented with rIL-2
was greater (pc.Ol) than that in cultures without rIL-2, a dosedependent decrease in proliferation with the addition of HCCM was
observed even in cultures with 200 U/ml of rIL-2 (pc.Ol). Furthermore,
results from the regression analysis showed that both treatment curves
were linear with the same slope (p>.05) and only the intercepts were
different (pc.Ol). Similarly, in Figure 13, regression analysis was
used to determine that the slopes of the two treatment curves, PHA and
PHA + HCCM, were linear and did not differ (p>.05). Again, only the
intercepts were different (pc.Ol). The results of the 3 x 7 factorial
ANOVA and Tukey mean comparisons showed that overall proliferation in
HCCM II-treated cultures was less (pc.Ol) than that in PHA control
cultures, but greater (pc.Ol) than that in non-stimulated cultures.
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HCCM (nl/well)

Figure 12. Effect of human recombinant IL-2 supplementation (200
U/ml) on proliferation of HCCM I-treated,
PHA-stimulated equine
PBLs. Data represent mean % of control (no HCCM or rIL-2 added) —
SEM for between lymphocyte population variation (n=3). In both rIL-2
supplemented and non-supplemented cultures, cell proliferation
decreased (pc.Ol) with the addition of HCCM I.
Different
superscripts designate within treatment differences (a-c and a'-e"
for within IL-2 and no IL-2 treatments, respectively; pc.Ol; Tukey).
There was no treatment x HCCM interaction (p>.05) . Although the
intercepts of the two treatment curves were different (pc.Ol), the
linear slopes of the two curves did not differ (p>.05; ANOR; r 2=.84).
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Effect of rIL-2 supplementation to nonstimulated,
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Data represent mean cpm — SEM for
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104

CTLL-2

Cells

and

Murine

Splenocytes.

CTLL-2

cell

proliferation in response to exogenous rIL-2 was not affected by the
addition of the >100,000 MW fraction of HCCM, or the two fractions of
CM (Table 7). However, the <100,000 MW fraction of HCCM did inhibit
CTLL-2 proliferation (p<.01). While there was no treatment x rIL-2
interaction (p>.05), only in the standard did a decrease in rIL-2
result in a significant decrease in cell proliferation (p<.05). HCCMSF appeared to be effective at suppressing PWM-stimulated murine
splenocytes as

incorporation of

thymidine was less (px.01) in

cultures treated with the >100,000 MW HCCM fraction than that in
cultures treated with the > 100,000 MW CM fraction. However, there
were no differences in proliferation between treatments within ConA or
PHA (p>.05).
FACS Analysis.

Data from the FACS analysis are recorded in

Table 8. Because of the 96 h culture period prior to cell labeling and
fixing, the cell concentration in each flask differed from the initial
1 x 10^/ml, with there being a decrease in cell number in the control
flask and an increase in the mitogen-stimulated flasks. For this
reason, the data are presented as final cell numbers/ml. Relative to
non-stimulated controls, there was an increase in total T cells with
both

PHA

and

EVJM

stimulation

(+36,000

and

+11,000

cells/ml,

respectively). However, a more exaggerated increase in B cells was
observed

with

both

mitogens

(+238,000

and

+236,000

cells/ml,

respectively). The addition of HCCM to PHA-stimulated cells resulted
in a decrease of 66,000 T and 20,000 B cells/ml when compared to PHAstimulated cells without HCCM. When HCCM was supplemented to PVMstimulated cells, again, a decrease in T cells occurred

(-19,000

TABLE 7.

Effect of fractionated HCCM II and CM on CTLL-2 cells and murine splenocytes.

Standard
CTLL-2 cells13
rL-2 (U/ml)
12.5
13.41
6.25
13.48
3.125 13.42
1.56
10.70
Mitogen
PWM
Con A
PHA

±
±
±
±

.45
.66
.51
.48*

<100c

6.28
6.69
6.49
5.80

± 1.08
— .19
± .42
± 1.14

<100
28.20 ± 2.03
52.49 ± 7.21
13.23 ± 1.78

HCQMg__________
>100d

13.44
13.68
13.38
11.21

± 1.52
± .69
± .77
± .98

>100
2.79 ± .52**
26.45 ± 6.76
16.50 ± 3.14

CMa
<100d

10.45
13.03
10.34
9.05

±
±
±
±

.96
.51
.88
.86

<100
32.67 ± 4.96
48.32 ± 8.35
19.44 ± 4.71

>100d

11.55
13.89
12.23
11.98

±
±
±
±

.17
.68
.82
.18

>100
40.28 ± 1.53
36.59 ± 9.76
18.24 ± 4.78

aHCCM II and CM were separated into two fractions, <100,000 MW and >100,000 MW as indicated by <10.0 and
>100, respectively. Sample fractions were supplemented to cultures at 200 |ll/ml.
^Values represent cpm — SEM (x 10”^) for triplicate wells.
^Different superscripts designate between treatment differences in %-thymidine incorporation(p<.01; Tukey
mean comparisons). There was no treatment x rIL-2 interaction (P>.05).
Values represent cpm — SEM (x 10“3) for quadruplicate wells.
*Designates significant difference as compared to other rIL-2 levels within column (p<.05; Tukey).
**Designates within row difference as compared to the similar MW fraction of CM (p<.05; Tukey) .
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TABLE 8.

Fluorescence activated cell sorter analysisa .

Treatment*3
mAb

PWM

PWM+

640 ± 40

681 ± 75

662 ± 32

Control

BT23A

(Total T)

670 ± 55

706 ±

.5

HT14A

(T subset)

77 ± 11

162 ± 16

150 ± 28

111 ±

191 ± 59

429 ± 10

409 ± 17

427 ± 20

8

95 ± 23

IgG-FITC

(B cells)

Change in
T cells (xlO3):
Change in
B cells (xlO3):

328 ±

8

+ 36

- 30

+ 11

-

+ 238

+ 218

+ 236

+ 137

8

aValues represent average number of antibody-labeled
cells/ml — SEM (x 10-3) for two lymphocyte populations and
the average change in cell number as compared to the
control.
^Culture treatments are: Control - no mitogen or HCCM; PHA
- PHA-stimulated; PHA+ - PHA-stimulated and HCCM II treated;
PWM - PWM-stimulated; PWM+ - PWM-stimulated and HCCM II
treated.
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celIs/ml)

and an even greater decrease in B cells was also observed

(-99,000 cells/ml). The presence of HCCM in PHA- and PWM-stimulated
cultures decreased the T suppressor cell subset by 12,000 and 16,000
cells/ml,

respectively,

as compared

to

stimulated

controls.

All

mitogen-stimulated cell populations contained a greater number of B
cells than did the control cultures, tut the T cell population
decreased below control culture levels when HCCM was supplemented to
the stimulated cultures

(-30,000 and -8,000). The change in the

approximate number of blast cells detected by side and forward light
scatter analysis correlated with what was observed with final cell
concentration in the FACS cultures and with -^-thymidine uptake data
from the lymphocyte proliferation assays (Fig. 14). Compared to PHAand EWM-stimulated controls, the average percent blast cells in HCCMtreated cultures decreased from 42.8 to 25.8 and 42.2 to 8.9 %,
respectively.
DISCUSSION
T lymphocytes are largely responsible for the actions of cellmediated immunity. Allograft rejection is caused mainly by T cells,
although antibodies produced by B cells can also play an important
role. The early developing fetus and the protective placental tissue
surrounding it, express antigens that are foreign to the mother
(Chatterjee-Hasrouni

and

Lala,

1979;

Jenkinson

and

Owen

1980;

Billington and Burrows, 1986; Zuckermann and Head, 1986; Allen et al.,
1987). During successful pregnancies, fetal antigens do not initiate a
cell-mediated rejection response, even though immune cells are present
at

the

feto-matemal

interface

(Beer

et

al.,

1975).

An

immunosuppressive substance (HCCM-SF) produced by the conceptus and
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Side

Scatter
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Forward Scatter

Forward Scatter

Figure 14.
Two-dimensional scatter analysis with side
and forward light scatter parameters was used to examine
the effect of HCCM on cell blastogenesis.
The blast cell
populations in HCCM-treated and non-HCCM-treated, mitogenstimulated cultures were compared.
Gate settings were
adjusted by comparing the mitogen-stimulated control to the
non-stimulated control, such that the window contained the
blast cells present only in the stimulated cell population.
The same settings were then applied to the 2-D scatter plot
of the HCCM-treated cell population.
A. PWM-stimulated,
HCCM-treated cell population (PWM+) of
sample #384.
The same w i n d o w used in A was used to
determine the percent blast cells (5.2%).
B.
PWM-stimulated cell population (PWM) of sample #384.
Window contains the larger cells (blast cells; 33.3%) that
were absent from the non-stimulated cell population.

!
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acting on the T cells mar/ be inhibiting the T cell response to fetal
antigens, thereby interfering with the otherwise eminent allograft
rejection response. Likewise, this localized T cell suppression could
also affect B cell proliferation, resulting in a reduction in antibody
production at the site of implantation. Maternal systemic immune
response,

awary from localized HCCM-SF, would be unaffected. This

hypothesis would explain why immune function of pregnant females is
not compromised and anti-fetal antibodies are

found in maternal

circulation of 90% of normal equine pregnancies (Allen et al., 1987),
yet the conceptus remains unharmed.
Through the use of PHA, a potent T cell stimulator, FWM, a T
cell-dependent B cell stimulator and LPS, a T cell-independent B cell
stimulator

(Sharon,

1983; Jelinek and Lipsky,

1987), we obtained

evidence indicating that the T cell population is directly affected fcy
HCCM-SF. Possibly due to the potent stimulatory effect of PHA on T
cells, relatively high concentrations (10-20%) of HCCM were required
before a decrease in cell proliferation was observed.

Supporting

evidence for the suppression of T cells by HCCM was provided by the
FACS analysis results which show the presence of HCCM decreased the T
cell population by 66,000 cells/ml as compared to PHA-stimulated
control cultures. While PHA-stimulation caused a dramatic increase in
the B cell population compared to the control, there was only a
minimal decrease of B cells when HCCM was also present in the culture.
In contrast to PHA-stimulated cultures, PWM-stimulated cells appeared
to be highly vulnerable to HCCM suppression as indicated by a rapid
decline

in

their

proliferative

response

at

very

low

HCCM

concentrations. The FACS data indicated that with PWM-stimulation
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there was only a minimal difference between T cell populations of
HCCM-treated and non-treated cultures, but a dramatic decrease in B
cell number. Because B cell proliferation depends on T cell-derived
lymphokines (Howard and Paul, 1983), HCCM suppression of T cells would
inhibit the production of

T

cell

affecting the B cell population.

factors,

thereby

indirectly

Since FWM is a weak T

cell

stimulator, the loss of even a small portion of T cells may decrease
lynphokine production to such low concentrations

that

a

severe

reduction of B cell proliferation, as that observed with the FACS
analysis, results. The hypothesis that HCCM does not act directly on B
cells is further supported by the fact that HCCM is ineffective at
suppressing proliferation of cultures stimulated with LPS. As LPS acts
on B cells without a requirement for T cells, the effect of HCCM on
the T cell population does not alter the B cell response to LPS. The
overall effect of HCCM-SF on mitogen-stimulated blastogenesis is most
visually obvious in the FACS two-dimensional scatter analysis. Since
light scatter parameters allow the sorting of cells by size and
density,

the blast cells can be

identified.

The two-dimensional

scatter plot quite effectively demonstrates the decrease in blast
cells when HCCM is present in the culture.
The process from initial lymphocyte stimulation to actual cell
proliferation involves critical intermediate events. Mitogens will
initiate cell activation within the

first 6 h

of

culture

and

lynphokine production follows (Weiss et al., 1987). Peak levels of
lymphokines are produced 24 to 48 h after initial stimulation, but
after 24 h, there is an increased expression of lynphokine receptors
and the cells begin to use the lymphokines produced (Altman et al.,

Ill

1990).

The

lyirphokine-receptor interaction acts

as

a

secondary

stimulus for promoting activated cell proliferation. Both B and T
lyirphocytes require T cell derived lymphokines such as IL-4 and IL-2,
respectively. Therefore, if T cell activation or T cell production of
lynphokines is inhibited, both B and T cell proliferation will be
suppressed. Data from experiments relating to the temporal effect of
HCCM on stimulated lyirphocytes support the hypothesis that HCCM
inhibits lynphokine production and/or lynphokine receptor expression
fcy T

cells.

HCCM

is

largely

ineffective

at

suppressing

cell

proliferation if added 48 h after the start of stimulation. Since most
cells have received both primary (mitogen) and secondary (lynphokine)
stimulation at 48 h,

these results

indicate

that

HCCM-SF must

interfere with these initial events and that it does not affect the
later events involved with proliferation. Treating cells with HCCM 24
h after the start of stimulation allowed the cells time to become
activated fcy mitogen and to begin producing lyrrphokines, however, few
of the cells had teen fully stimulated fcy the secondary lyirphokinereceptor interaction prior to HCCM treatment, and thus, the suppressor
factor was effective.
Although little is known afcout how HCCM-SF acts on the cells, we
have shown that pre-treatment of cells for 24 h with HCCM, followed by
thorough

rinsing,

resulted

in

a

cell

population

with

full

proliferative capacity when subsequently stimulated with mitogen.
These data demonstrate many important characteristics of HCCM-SF. The
factor is obviously not cytotoxic and exhibits only a transient effect
on lymphocyte proliferation. Furthermore, the fact that HCCM treatment
does not exhibit any long-term effects

on

a

cell population's
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responsiveness,

indicates that HCCM suppression

is

not

mediated

through T suppressor cell recruitment and/or activation. The FACS data
support this conclusion by demonstrating a decreased number of T
suppressor cells in cultures treated with HCCM.

Because

proliferation of T lyirphocytes depends largely on their ability to
produce and respond to IL-2, an efficient mechanism for suppressing
these cells would be an inhibition of IL-2 production. There is in
vivo evidence that administration of antibodies to IL-2 can extend
allograft

acceptance

(Kirkman

et

al.,

1985).

Furthermore,

administration of a high IL-2 dose to mice terminates a successful
ongoing pregnancy (Lala et al., 1990). It seems IL-2 plays an integral
role

in

allograft

acceptance

and

rejection.

Considering

this

association, it is not surprising that many studies have been carried
out examining the effect of conceptus or uterine derived suppressor
factors on lymphocyte production of IL-2 and/or expression of IL-2R.
In many cases the data indicate that a relationship exists between
these suppressor factors and IL-2 production (Segerson, 1988; Saito et
al., 1990; Segerson and Gunsett, 1990; Segerson and Libty, 1990).
Since HCCM-SF acts on T lyirphocytes and is only effective if present
during the first 48 h of stimulation, it is possible the suppressor
mechanism is mediated through the inhibition of IL-2 production. Our
initial attempt to overcome a potential deficiency of IL-2 in HCCMtreated cultures fcy supplementing the cultures with PEMCS, was not
particularly effective. Since it has been shown that stimulated equine
lymphocyte supernatant contains the lymphokines required to support
IL-2 dependent cell responses (Magnuson et al., 1984), we expected our
PBMCS to contain high levels of IL-2, but our attempt to quantify this
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IL-2 was unsuccessful because the murine-derived CTLL-2 cells did not
respond to equine PBMCS.
Our attempt to override the suppressive activity of HCCM by
supplementing

cultures

with

rIL-2

at

200

U/ml

also

proved

unsuccessful. The addition of this high concentration of rIL-2 should
compensate for an IL-2 deficiency in the cultures. The fact that HCCM
suppressed proliferation of cells, even in the presence of an over
abundance of rIL-2, demonstrates that HCCM suppression is not solely a
result of deficient IL-2 production. Furthermore, because the slopes
of the treatment curves in Figure 12 are the same, we can conclude
that the suppressive activity of HCCM remains the same, regardless of
the IL-2 concentration in the culture. Because a sub-optimal dose of
PHA was used in the cultures, an IL-2 deficiency existed and the
enhanced proliferation observed in the rIL-2 supplemented cultures
simply reflects the effect of sufficient IL-2 on those cells not
suppressed fcy HCCM-SF. One explanation for the inability of rIL-2 to
overcane HCCM-induced suppression is that HCCM-SF is inhibiting IL-2R
expression,

rendering some cells incapable of responding to the

exogenous rIL-2. Alternatively, HCCM-SF may be acting fcy interfering
with the necessary IL-2/IL-2R interactions. Finally, as very high
levels of IL-2 will activate T and B cells via the intermediate
affinity p-75 £ receptor (Cosman et al., 1987), it is possible the
high concentration of rIL-2 supplemented to the cultures stimulated
cells not expressing the high affinity IL-2R,

thereby increasing

proliferation in the HCCM-treated cultures.
Because CTLL-2 cells continuously express the high affinity IL2R, they were used to test the hypothesis that HCCM-SF interferes with
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the ZL-2/IL-2R interaction.

We

found that only the <100,000 MW

fraction of HCCM inhibits CTLL-2 cell proliferation, possibly due to
hormones and/or interferons produced by the horse conceptus. More
important, our data show that the >100,000 MW fraction of HCCM exerts
no suppressive effect on the CTLL-2 cell response to rIL-2. The fact
that murine splenocytes are suppressed if treated with 200 ^il/ml of
the >100,000 MW fraction of HCCM (the same concentration used on the
CTLL-2 cells), indicates that
cells is not simply

the ineffectiveness of HCCM on CTLL-2

due to species specificity of the suppressor

factor. These results suggestthat HCCM-SF interferes with cellular
events prior to the expression of the high affinity IL-2R, but is not
capable of suppressing cell proliferation following IL-2R expression.
However, there does exist the possibility that the CTLL-2 cells differ
significantly from T cells found in vivo,

and thus may not be

vulnerable to the suppressor activity of HCCM-SF.
Because

HCCM-SF

does

not

interfere

with

the

IL-2/IL-2R

interaction, we investigated the possibility that the high levels of
exogenous rIL-2 activate T and B cells via the intermediate affinity
p-75 £ receptor,
cultures.

thereby increasing proliferation in HCCM-treated

In Figure13

we

show

that

with

increasing

rIL-2

concentrations, proliferation in non-stimulated cultures increased and
then plateaued. The initial increase could be attribated to the effect
of high rIL-2 levels on the p-75 £ receptors. A rIL-2 associated
increase in proliferation was also observed in cultures of both PHAstimulated treatment groups because sub-optimal PHA was used, and
thus, IL-2 was deficient until cultures were supplemented with rIL-2.
If rIL-2

supplementation

increased proliferation

of

HCCM-treated

115

cultures only fcy activating cells via intermediate affinity receptors,
a dose-dependent increase in proliferation would not result, and the
slope of the PHA + HCCM treatment curve would be the same as that of
the non-stimulated treatment curve. In contrast, the slope of the PHA
+ HCCM curve was the same as that of the PHA curve,

indicating

proliferation was mediated via high affinity IL-2R on activated cells.
However, it is important to note that the relative difference in
proliferation between these two treatments remained constant at all
levels of rIL-2, indicating that, while the effect of rIL-2 was
similar in both treatments,

there were

fewer

cells

capable of

responding to the rIL-2 in the PHA + HCCM cultures. The results from
Figures 12 and 13 and the CTLL-2 assay suggest that, in cultures
treated with HCCM, there exist fewer IL-2R expressing cells capable of
responding to rIL-2. These results are in agreement with reports fcy
Bulmer and Johnson (1986) who found that T lymphocytes in human
decidua do not express IL-2Rs.

Still,

there seems to exist sane

activated cells that do express the IL-2R and exogenous rIL-2 enhances
their proliferative response. It is not known whether IL-2R expression
is

inhibited

fcy

HCCM-SF

directly

or

indirectly

through

the

interference of HCCM-SF with other early events in T cell activation.
T cell expression of the high affinity IL-2R requires multiple
signals, including antigenic stimulation in the context of self-major
histoccnpatibility antigens and the macrophage product IL-1 (Gery et
al., 1972). Our use of mitogens to stimulate the cells ofcrviated the
need for anitigenic stimulation, thus precluding the possibility that
suppression involved an alteration in the function of the T cell
antigen-specific receptor. We cannot rule out the possibility that
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suppression results from an alteration in the production or function
of H.-1. Such a mechanism of suppression has been suggested for a
human placental protein (Pockley and Bolton, 1989).
If HCCM-SF is interfering with IL-2R expression, it is possible
that it is actually acting directly on both B and T cells. FWMstimulated B cells express the IL-2R (Waldmann et al., 1984) while
LPS-stimulated B cells do not (Leibson et al., 1981; Robb et al.,
1981), thereby indicating that IL-2Rs play an important role in EMIstimulated

B

cell

proliferation.

HCCM-SF

inhibition

of

IL-2R

expression may imply a mechanism acting directly on B cells and
indirectly, through T cell suppression, resulting in the loss of B
cells and lack of ^H-tbymidine incorporation in PWM-stimulated, HCCMtreated cultures. Furthermore, as neither IL-2Rs nor T cells seem to
be involved with LPS-stimulated B cell proliferation, it would follow
that we would not observe suppression of such cultures with HCCM
supplementation.
In a previous

study,

we

reported

the

production

of

an

immunosuppressive factor produced by Day 10 - Day 26 horse conceptuses
(Roth et al., 1990). In that study,

the conceptus cultures were

carried out as those described herein for obtaining HCCM I. In this
study, we cultured Day 20 conceptuses in medium without PCS, thereby
obtaining HCCM II. The immunosuppressive characteristics of HCCM I and
II appear to be similar, indicating that supplementation of FCS to the
culture medium is not required by horse conceptus tissue for the
production

of

the

suppressor

factor.

HCCM-SF

is

>100,000

MW,

suppresses proliferation of T lymphocytes and seams to indirectly
suppress B lymphocytes.

This

non-cytotoxic

suppressor

factor

is
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effective only if present during the early stages of lymphocyte
activation and its effect on cells is completely reversible. It is
important that the suppressor factor is not cytotoxic, as excessive
cell death at the feto-matemal interface could lead to the release of
lysozymes and interferons resulting in an unhealthy environment for
placental development. Furthermore,

the lack of toxicity and the

transient suppressive effect of HCCM, ensures that its effect is
localized and that the systemic maternal immune system is not downregulated or detrimentally altered by HCCM-SF during pregnancy. HCCM
suppression is highly dependent on the suppressor factor's ability to
act on the cells during the early stages of activation and could
explain why such factors are produced by horse embryos as early as Day
10 (Roth et al., 1990). At this stage of development, the embryo is
still highly mobile and is enclosed in the protective embryonic
capsule. By day 15, when uterine migration ceases (Ginther, 1986) and
the conceptus becomes more intimately associated with maternal tissue,
the concentration of suppressor factor in utero may be high enough
that local maternal T cell quiescence is maintained. Because of its
suppressive effect on T cells, HCCM-SF could play a role in preventing
lynphocyte destruction of endometrial cups prior to day 120 of
pregnancy.

Our results suggest that

the

factor

suppresses

cell

proliferation by preventing IL-2R expression. In view of the fact that
T cells are largely responsible for allograft rejection, and the IL2/IL-2R interaction is a prerequisite for complete T cell activation,
we hypothesize that this suppressor factor,

by inhibiting IL-2R

expression, disrupts the T cell-mediated allograft rejection that
might otherwise terminate pregnancy.

SUMMARY AMD CONCLUSIONS
One aspect of the fetal-maternal immunological relationship was
studied.

In our

initial

experiment,

immunosuppressive

activity-

derived from sheep, goat and sheep x goat hybrid trophoblast tissue
obtained at day 20 of gestation was examined.

Medium conditioned by-

all three types of trophoblast similarly suppressed both sheep and
goat

lyirphocytes.

The

results

from this

study

indicate

that

suppressor factors are secreted fcy hybrid trophoblast at day 20 of
gestation and these factors do not differ from those of sheep and goat
trophoblast

tissue

in

their ability

to

suppress

FWM-stimulated

lymphocytes.
All

subsequent

studies,

in

which

conceptus-derived

immunosuppressor activity was studied in greater detail, were carried
out with the horse conceptus.

The equine model was chosen because it

is unique in that hybrid and interspecific pregnancies are successful,
yet the characteristic events involved in placental formation and
subsequent
pregnancy.

function differ depending on

the particular

type

of

Prior to this study, horse conceptus immunosuppressor

factors had not been described.

Therefore, we first identified the

presence of a non-antigen specific immunosuppressive factor produced
fcy horse embryos from day 9 through at least day 26 of development.
While we refer to this factor in the singular tense, it is quite
possible

there

is

more

than

one

factor

responsible

for

the

immunosuppressive activity.
Initially we determined that the suppressor factor is >30,000 MW
and extremely stabile under harsh treatments.

EXie to its size and

stability, the factor does not appear to be a hormone or interferon.
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HCCM-SF exhibits its suppressive effect in a similar manner on donkey
and horse lyirphocytes, yet is less effective on the less-related goat
lyirphocytes.

These results differ from those of the preliminary

sheep, goat, hybrid study where the suppressor activity in the
conditioned medium from these species
specificity.

This difference may

did not

simply

exhibit

reflect

the

speciesincreased

sensitivity of the equine assay relative to that of the sheep/goat
assay.
In the third experiment, the effect of indomethacin on the
production of the suppressor factor was examined.

Horse trophoblast

tissue from 21 day-old conceptuses was cultured for 24 h in the
presence or absence of 10“4 M indomethacin.
and

the

suppressive

determined.

activity

of

the

The concentration of PGE2
conditioned

mediums

were

While PGE2 was reduced ky 91%, the suppressive activity

of the two mediums did not differ.

Thus, in contrast to results from

a number of studies with other species which have indicated the
involvement of PGE2 in conceptus-derived suppressor activity, our data
indicate that the horse trophoblast-derived immunosuppressor is not
associated with prostaglandin production.
In our final series of experiments we examined the suppressive
mechanism of HCCM-SF.

Using microconcentrator centrifugation, we

found that HCCM-SF is >100,000 MW.
analysis

in

which

lymphocyte cultures,

we

compared

Results obtained from the FACS
HCCM-SF-treated

indicated that HCCM-SF

lyirphocytes and indirectly on B lyirphocytes.
largely

confirmed

with

results

obtained

acts

to

non-treated

directly

on T

This conclusion was
from

HCCM-SF-treated

lymphocyte proliferation cultures in which mitogens with different
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specificities were used.

In addition, we determined that this factor

is not cytotoxic, affects cells during the early stages of activation
and

does

not

permanently

suppress

the

lyirphocytes.

These

characteristics of HXM-SF are important for the following reasons:
1) if cytotoxic, HXM-SF would cause excessive cell death at the
fetal-maternal interface, likely resulting in an unhealthy environment
for fetal development, 2) if the effect of HXM-SF was cytotoxic
and/or irreversible, it might detrimentally alter maternal systemic
immunity and, 3) the fact that HXM-SF must affect cells prior to
their complete activation could explain why HXM-SF is produced fcy
embryos prior to the cessation of uterine migration and the initiation
of implantation.

Furthermore, we found that a high concentration of

human rIL-2 could not override the suppressive effect of HXM-SF in
lymphocyte cultures.

However, IL-2R expressing CTLL-2 cells were not

inhibited fcy HXM-SF. These results indicate that HXM-SF inhibits T
cell expression of the IL-2R.
In

summary,

immunosuppressive

a

factor

high-molecular-weight
is

implantation horse conceptuses.

produced

fcy

early

(>100,000
and

late

MW)
pre-

This factor is very stabile, is not

cytotoxic and is not associated with PGE2.

It effects T lymphocytes

early during cell activation fcy inhibiting the expression of the IL-2R
and, therefcy, may play a role in disrupting T cell-mediated allograft
rejection that might

otherwise

terminate pregnancy.

While

no

difference in sheep, goat and sheep x goat fcybrid trophoblast tissuederived suppressor activity on

sheep and goat

lymphocytes

was

identified, HXM-SF did exhibit same degree of species-specificity.
Together, these data indicate an important immunoregulatory role for

121

soluble

trophoblast-derived

factors

that

may

facilitate

fetal

allograft survival and that may also be associated with the success or
failure of

interspecies pregnancies.

With

this

newly

acquired

knowledge about the effect of HCCM-SF on horse lyirphocytes, we can
begin to examine similar factors and their effects on maternal
lyirphocytes during interspecific and hybrid pregnancies

to more

accurately assess the role of these factors in fetal allograft
protection.
Future Work
While a large body of information pertaining to HCCM-SF has been
accumulated, a great deal remains unknown and is worthy of further
investigation.

The objectives of future studies might be to determine

both the physical nature and the physiological activity of this
factor(s).

Column chromatography might prove to be a viable method

for determining the actual size of HCCM-SF.

Numerous techniques, such

as charcoal extraction, lipid extraction, glycosidase digestion and
dithiothreitol reduction, could potentially be used to biochemically
define HCCM-SF.

Although we have identified some of the effects of

HCCM on lynphocytes, its mechanism of suppression is not yet fully
understood.

As IL-1 plays a major role in lymphocyte activation, both

the effect of HCCM on IL-1 production and the ability of exogenous IL1 to overcane HCCM suppression should be investigated.

Studies could

also be carried out to examine the effect of HCCM on intracellular
events during cell activation, such as Ca+ release.

The results of

such studies might lead to a more complete understanding of how
lymphocyte quiescence is maintained in HCCM-treated cultures.
might also be possible to obtain more direct evidence of

It
IL-2R
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involvement in T
directly

measuring

populations.

lymphocyte suppression fcy using ^^I-rIL-2
IL-2R

on

HCCM-treated vs.

non-treated

and
cell
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APPENDIX
In addition to the studies described in Chapters II - V, several
experiments were carried out that were never published and/or fully
completed.

The information gained from these additional experiments,

although sometimes inconclusive and/or preliminary, may be useful to
those specifically

interested

immunosuppressive factors.

in characterizing

Therefore,

I have

conceptus-derived
included

in this

appendix a brief summary describing the studies, the rationale behind
them and the results.
While concluding that HCCM-SF is >100,000 MW and therefore not a
steroid hormone, we questioned the possibility that hormones attached
to larger molecules (carrier proteins) could remain in the retentate
fraction during centricon centrifugation and thus, be active in the
>100,000 MW fraction.

RIAs were used to determine the concentration

of progesterone and estrogen in HCCM, and to determine if the steroids
were passing through the centricon membrane.

A sample of HCCM was

separated ly centricon centrifugation and each fraction (>100,000 and
<100,000 MW) and an aliquot of unfractionated HCCM were analyzed.
Results

from

the

RIAs

indicated

that

the

concentrations

of

progesterone and total estrogen in the unfractionated sample of HCCM
are much lower (2 to 7 ng/ml and 1 to 10 ng/ml, respectively) than
those required for suppressing lymphocytes in proliferation assays.
Furthermore, the fact that 75 to 100% of the hormones were identified
in the <100,000 MW aliquot of the fractionated HCCM clearly indicated
that the hormones were passing through the centricon membrane. These
results support our conclusion that the suppressive activity of HCCM
is not due to steroid hormones.
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In addition to the studies described in chapter III,

two

experiments designed to alter the immunosuppressive activity of HCCM
were carried out.

In the first experiment, the pH of HCCM (pH = 8.2)

was altered fcy the addition of IN HCl or NaOH to become acidic (pH =
2.0) or basic (pH = 12.0), respectively.

The two samples were

maintained at room terrperature for 1 hour, neutralized (pH = 8.0),
fractionated through 10,000 MW exclusion centricons and tested for
suppressive activity.

While similarly treated CM

exhibited no

suppressive effect, both acid and base treated samples of HCCM
retained significant suppressive activity.

However, it is possible

the activity was reduced from that of fresh HCCM.
experiment HCCM was subjected to protease digestion.

In a second

Aliquots of HCCM

and CM (800 pil; w/o FCS) were combined with 40 mg of protease beads
and were rocked on a tube rocker for 24 hours at room terrperature.
Following digestion,

samples were fractionated with a 100,000 MW

exclusion centricon and retentate volumes (>100,000 MW) were tested
for suppressive activity.

Protease-treated HCCM exhibited suppressive

activity equal to that of non-treated HCCM.
The protein content in samples of HCCM lacking any exogenous
protein source, was determined using a Bio Rad protein determination
assay.

Aliquots of HCCM from 20-day-old conceptuses

cultured in 20 ml RHCE) were analyzed.

(n=6;

each

The protein content ranged

from .025 to .078 ng/ml with an average of .055 ng/ml.
Polyacrylamide

gel

electrophoresis

concentrated samples of HCCM (5X; n=6).

was

carried

out

with

Separating gels (both 7.5%

and 10% acrylamide) were stained with coomassie blue.
bands stained uniformly across all samples,

While numerous

there were no bands
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distinguishing proteins >100,000 MW on the gels.

Furthermore, in

lanes where only the >100,000 MW fraction of HCCM was applied, there
were no distinct bands.

However, there was evidence of staining at

the top of the gel indicating the possible existence of highnolecular-weight proteins that never entered the separating gel.
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